Document

0000898770-17-000010.txt : 20171101 0000898770-17-000010.hdr.sgml : 20171101 20171101122605 ACCESSION NUMBER: 0000898770-17-000010 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 54 CONFORMED PERIOD OF REPORT: 20170930 FILED AS OF DATE: 20171101 DATE AS OF CHANGE: 20171101 FILER: COMPANY DATA: COMPANY CONFORMED NAME: SHARPS COMPLIANCE CORP CENTRAL INDEX KEY: 0000898770 STANDARD INDUSTRIAL CLASSIFICATION: HAZARDOUS WASTE MANAGEMENT [4955] IRS NUMBER: 742657168 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-34269 FILM NUMBER: 171168084 BUSINESS ADDRESS: STREET 1: 9220 KIRBY DRIVE STREET 2: STE 500 CITY: HOUSTON STATE: TX ZIP: 77054 BUSINESS PHONE: 713-432-0300 MAIL ADDRESS: STREET 1: 9220 KIRBY DRIVE STREET 2: STE 500 CITY: HOUSTON STATE: TX ZIP: 77054 FORMER COMPANY: FORMER CONFORMED NAME: US MEDICAL SYSTEMS INC DATE OF NAME CHANGE: 19970128 FORMER COMPANY: FORMER CONFORMED NAME: MEDICAL POLYMERS TECHNOLOGIES INC DATE OF NAME CHANGE: 19930916 10-Q 1 q1form10q.htm 10-Q Q1 FY18 Document

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

___________________

FORM 10-Q


ý	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2017


¨	TRANSITION REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to .

Commission File Number: 001-34269

_______________________

SHARPS COMPLIANCE CORP.

(Exact name of registrant as specified in its charter)



Delaware	74-2657168
(State or other jurisdiction of	(I.R.S. Employer Identification No.)
incorporation or organization)



9220 Kirby Drive, Suite 500, Houston, Texas	77054
(Address of principal executive offices)	(Zip Code)

(713) 432-0300

(Registrant’s telephone number, including area code)

Indicate by check mark if the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ý No o

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).

Yes ý No

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Securities Exchange Act of 1934.




Large Accelerated Filer o	Accelerated Filer o	Non-accelerated Filer o (Do not check if a smaller reporting company)	Emerging growth company company o	Smaller reporting company ý

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12(b)-2 of the Exchange Act). Yes o No ý

As of October 30, 2017, there were 16,008,412 outstanding shares of the Registrant's common stock, par value $0.01 per share.



SHARPS COMPLIANCE CORP. AND SUBSIDIARIES


PART I	FINANCIAL INFORMATION	PAGE

Item 1.	Condensed Consolidated Financial Statements	3

	Condensed Consolidated Balance Sheets as of September 30, 2017 and June 30, 2017	3

	Condensed Consolidated Statements of Operations for the three months ended September 30, 2017 and 2016	4

	Condensed Consolidated Statements of Stockholders’ Equity for the three months ended September 30, 2017 and year ended June 30, 2017	5

	Condensed Consolidated Statements of Cash Flows for the three months ended September 30, 2017 and 2016	6

	Notes to Condensed Consolidated Financial Statements	7

Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	14

Item 4.	Controls and Procedures	20

Part II	OTHER INFORMATION

Item 1.	Legal Proceedings	20

Item 1A.	Risk Factors	20

Item 2.	Unregistered Sales of Equity Securities And Use Of Proceeds.	20

Item 6.	Exhibits	21

	SIGNATURES	21

PART I – FINANCIAL INFORMATION

ITEM 1. FINANCIAL STATEMENTS

SHARPS COMPLIANCE CORP. AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS

(Unaudited)

(In thousands, except share and par value)



	September 30,			June 30,
	2017			2017

ASSETS
CURRENT ASSETS
Cash and cash equivalents	$	5,160		$	4,675
Accounts receivable, net of allowance for doubtful accounts of $80 and $78, respectively	7,279			7,553
Inventory, net	4,239			4,098
Prepaid and other current assets	566			694
TOTAL CURRENT ASSETS	17,244			17,020

PROPERTY, PLANT AND EQUIPMENT, net	6,491			6,543

OTHER ASSETS	122			120

GOODWILL	6,735			6,735

INTANGIBLE ASSETS, net	3,935			4,046

TOTAL ASSETS	$	34,527		$	34,464

LIABILITIES AND STOCKHOLDERS' EQUITY
CURRENT LIABILITIES
Accounts payable	$	1,978		$	1,710
Accrued liabilities	1,518			1,800
Current maturities of long-term debt	600			601
Deferred revenue	2,396			2,421
TOTAL CURRENT LIABILITIES	6,492			6,532

LONG-TERM DEFERRED REVENUE, net of current portion	528			478

OTHER LONG-TERM LIABILITIES	171			165

LONG-TERM DEBT, net of currrent portion	1,853			2,002

TOTAL LIABILITIES	9,044			9,177

COMMITMENTS AND CONTINGENCIES

STOCKHOLDERS' EQUITY
Common stock, $0.01 par value per share; 20,000,000 shares authorized; 16,304,027 shares issued and 16,008,412 shares outstanding	163			163
Treasury stock, at cost, 295,615 shares repurchased	(1,554		)	(1,554		)
Additional paid-in capital	28,184			28,063
Accumulated deficit	(1,310		)	(1,385		)
TOTAL STOCKHOLDERS' EQUITY	25,483			25,287

TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY	$	34,527		$	34,464

The accompanying notes are an integral part of these condensed consolidated financial statements.

SHARPS COMPLIANCE CORP. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(Unaudited)

(In thousands, except per-share data)



	Three-Months Ended September 30,
	2017			2016
REVENUES	$	9,683		$	9,531
Cost of revenues	6,655			6,572
GROSS PROFIT	3,028			2,959

Selling, general and administrative	2,725			3,699
Depreciation and amortization	202			200

OPERATING INCOME (LOSS)	101			(940		)

OTHER INCOME (EXPENSE)
Interest income	5			4
Interest expense	(24		)	(31		)
TOTAL OTHER EXPENSE	(19		)	(27		)

INCOME (LOSS) BEFORE INCOME TAXES	82			(967		)
INCOME TAX EXPENSE	7			—

NET INCOME (LOSS)	$	75		$	(967	)

NET INCOME (LOSS) PER COMMON SHARE - Basic and Diluted	$	0.00		$	(0.06	)

WEIGHTED AVERAGE SHARES USED IN COMPUTING INCOME (LOSS) PER COMMON SHARE:
Basic	16,008			15,868
Diluted	16,093			15,868

The accompanying notes are an integral part of these condensed consolidated financial statements.

SHARPS COMPLIANCE CORP. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY

(Unaudited)

(In thousands, except share data)



	Common Stock				Treasury Stock					Additional Paid-in Capital		Accumulated Deficit			Total Stockholders' Equity
	Shares		Amount		Shares		Amount			Additional Paid-in Capital		Accumulated Deficit			Total Stockholders' Equity

Balances, June 30, 2016		15,740,458	$	158	(295,615	)	$	(1,554	)	$	25,331	$	(92	)	$	23,843
Exercise of stock options		95,050	1		—		—			341		—			342
Stock-based compensation		—	—		—		—			496		—			496
Issuance of common shares for acquisition		415,527	4							1,895					1,899
Issuance of restricted stock		52,992	—		—		—			—		—			—
Net loss		—	—		—		—			—		(1,293		)	(1,293		)
Balances, June 30, 2017		16,304,027	163		(295,615	)	(1,554		)	28,063		(1,385		)	25,287
Stock-based compensation		—	—		—		—			121		—			121
Net income		—	—		—		—			—		75			75
Balances, September 30, 2017		16,304,027	$	163	(295,615	)	$	(1,554	)	$	28,184	$	(1,310	)	$	25,483

The accompanying notes are an integral part of these condensed consolidated financial statements.

SHARPS COMPLIANCE CORP. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited)

(In thousands)



	Three-Months Ended September 30,
	2017			2016
CASH FLOWS FROM OPERATING ACTIVITIES
Net income (loss)	$	75		$	(967	)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Depreciation and amortization	390			338
(Gain) loss on disposal of property, plant and equipment	(2		)	6
Stock-based compensation expense	121			139
Changes in operating assets and liabilities, net of effects of business acquisitions:
Accounts receivable	274			(772		)
Inventory	(72		)	(252		)
Prepaid and other assets	126			(213		)
Accounts payable and accrued liabilities	(29		)	644
Deferred revenue	25			285
NET CASH PROVIDED BY (USED IN) OPERATING ACTIVITIES	908			(792		)

CASH FLOWS FROM INVESTING ACTIVITIES
Purchase of property, plant and equipment	(235		)	(806		)
Cash proceeds from sale of property, plant and equipment	3			13
Additions to intangible assets	(41		)	—
Payments for business acquisitions, net of cash acquired	—			(7,062		)
NET CASH USED IN INVESTING ACTIVITIES	(273		)	(7,855		)

CASH FLOWS FROM FINANCING ACTIVITIES
Proceeds from exercise of stock options	—			141
Proceeds from long-term debt	—			3,000
Repayments of long-term debt	(150		)	(21		)
NET CASH PROVIDED BY (USED IN) FINANCING ACTIVITIES	(150		)	3,120

NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS	485			(5,527		)

CASH AND CASH EQUIVALENTS, beginning of period	4,675			12,435

CASH AND CASH EQUIVALENTS, end of period	$	5,160		$	6,908

SUPPLEMENTAL CASH FLOW DISCLOSURES:
Income taxes paid	$	3		$	—

Interest paid on long-term debt	$	17		$	22

NON-CASH INVESTING AND FINANCING ACTIVITIES:

Issuance of common stock for acquisition	$	—		$	1,889
Unpaid consideration related to acquisitions	$	—		$	140
Transfer of equipment to inventory	$	69		$	34
Property, plant and equipment financed through accounts payable	$	21		$	310

The accompanying notes are an integral part of these condensed consolidated financial statements.

SHARPS COMPLIANCE CORP. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

NOTE 1 - ORGANIZATION AND BACKGROUND

Organization: The accompanying unaudited condensed consolidated financial statements include the financial transactions and accounts of Sharps Compliance Corp. and its wholly owned subsidiaries, Sharps Compliance, Inc. of Texas (dba Sharps Compliance, Inc.), Sharps e-Tools.com Inc. (“Sharps e-Tools”), Sharps Manufacturing, Inc., Sharps Environmental Services, Inc. (dba Sharps Environmental Services of Texas, Inc.), Sharps Safety, Inc., Alpha Bio/Med Services LLC, Bio-Team Mobile LLC and Citiwaste, LLC (collectively, “Sharps” or the “Company”). All significant intercompany accounts and transactions have been eliminated upon consolidation.

Business: Sharps is a leading full-service national provider of comprehensive waste management services including medical, pharmaceutical and hazardous for small and medium quantity generators. The Company’s solutions include Sharps Recovery System™ (formerly Sharps Disposal by Mail System^®), TakeAway Medication Recovery System™, MedSafe^®, TakeAway Recycle System™,ComplianceTRAC^SM, SharpsTracer^®, Sharps Secure^®Needle Disposal System, Complete Needle™ Collection & Disposal System, TakeAway Environmental Return System™, Pitch-It IV™ Poles, Asset Return System and Spill Kit and Recovery System. The Company also offers its route-based pick-up service in a twenty-three (23) state region of the South, Southeast and Northeast portions of the United States.

NOTE 2 - BASIS OF PRESENTATION

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with the rules and regulations of the Securities and Exchange Commission (“SEC”) for interim financial information and with instructions to Form 10-Q and, accordingly, do not include all information and footnotes required under generally accepted accounting principles in the United States of America ("GAAP") for complete financial statements. Additionally, the preparation of the condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect reported amounts. In the opinion of management, these interim condensed consolidated financial statements contain all adjustments (consisting of normal recurring adjustments) considered necessary for a fair presentation of the consolidated financial position of the Company as of September 30, 2017, the results of its operations for the three months ended September 30, 2017 and 2016, cash flows for the three months ended September 30, 2017 and 2016 and stockholders’ equity for the three months ended September 30, 2017. The results of operations for the three months ended September 30, 2017 are not necessarily indicative of the results to be expected for the entire fiscal year ending June 30, 2018. These unaudited condensed consolidated financial statements should be read in conjunction with the Company’s Annual Report on Form 10-K for the year ended June 30, 2017.

NOTE 3 - SIGNIFICANT ACCOUNTING POLICIES

Revenue Recognition: The Company recognizes revenue when services are provided and from product sales when (i) goods are shipped or delivered, and title and risk of loss pass to the customer, (ii) the price is substantially fixed or determinable and (iii) collectability is reasonably assured except for those sales via multiple-deliverable revenue arrangements. Provisions for certain rebates, product returns and discounts to customers are accounted for as reductions in sales in the same period the related sales are recorded. Product discounts granted are based on the terms of arrangements with direct, indirect and other market participants, as well as market conditions, including prices charged by competitors. Rebates are estimated based on contractual terms, historical experience, trend analysis and projected market conditions in the various markets served. Service agreements which include a vendor managed inventory program include terms that meet the “bill and hold” criteria and as such are recognized when the order is completed, at which point title has transferred, there are no acceptance provisions and amounts are segregated in the Company’s warehouse. During both the three months ended September 30, 2017 and 2016, the Company recorded revenue from inventory builds that are held in vendor managed inventory under these service agreements of $1.0 million. As of September 30, 2017 and June 30, 2017, $2.9 million and $2.7 million, respectively, of solutions sold through that date were held in vendor managed inventory pending fulfillment or shipment to patients of pharmaceutical manufacturers who offer these solutions to patients in an ongoing patient support program.

Certain products offered by the Company have revenue producing components that are recognized over multiple delivery points (Sharps Recovery System and various other solutions like the TakeAway Medication Recovery Systems referred to as “Mailbacks” and Sharps Pump and Asset Return Systems, referred to as “Pump Returns”) and can consist of up to three separate elements, or units of measure, as follows: (1) the sale of the compliance and container system, (2) return transportation and (3) treatment service. In accordance with the relative selling price methodology, an estimated selling price is determined for all deliverables that qualify for separate units of accounting. The actual consideration received in a multiple-deliverable arrangement is then allocated to the units based on their relative sales price. The selling price for the transportation revenue and the treatment revenue utilizes third party evidence. The Company estimates the selling price of the compliance and container system based on the

SHARPS COMPLIANCE CORP. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

product and services, provided, including compliance with local, state and federal laws, adherence to stringent manufacturing and testing requirements, safety to the patient and the community as well as storage and containment capabilities.

Revenue for the sale of the compliance and container is recognized upon delivery to the customer, at which time the customer takes title and assumes risk of ownership. Transportation revenue is recognized when the customer returns the compliance and container system and the container has been received at the Company’s owned or contracted facilities. The compliance and container system is mailed or delivered by an alternative logistics provider to the Company’s owned or contracted facilities. Treatment revenue is recognized upon the destruction or conversion and proof of receipt and treatment having been performed on the container. Since the transportation element and the treatment elements are undelivered services at the point of initial sale of the compliance and container, transportation and treatment revenue is deferred until the services are performed. The current and long-term portions of deferred revenues are determined through regression analysis and historical trends. Furthermore, through regression analysis of historical data, the Company has determined that a certain percentage of all compliance and container systems sold may not be returned. Accordingly, a portion of the transportation and treatment elements are recognized at the point of sale.

Income Taxes: Deferred tax assets and liabilities are determined based on differences between financial reporting and tax bases of assets and liabilities and are measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse. A valuation allowance is established when it is more likely than not that some portion or all of the deferred tax assets will not be realized. The establishment of valuation allowances and development of projected annual effective tax rates requires significant judgment and is impacted by various estimates. Both positive and negative evidence, as well as the objectivity and verifiability of that evidence, is considered in determining the appropriateness of recording a valuation allowance on deferred tax assets. Under GAAP, the valuation allowance has been recorded to reduce the Company’s deferred tax assets to an amount that is more likely than not to be realized and is based upon the uncertainty of the realization of certain federal and state deferred tax assets related to net operating loss carryforwards and other tax attributes.

Goodwill and Other Identifiable Intangible Assets: Finite-lived intangible assets are amortized over their respective estimated useful lives and evaluated for impairment periodically whenever events or changes in circumstances indicate that their related carrying values may not be fully recoverable. Goodwill is assessed for impairment at least annually. The Company generally performs its annual goodwill impairment analysis using a quantitative approach. The quantitative goodwill impairment test identifies the existence of potential impairment by comparing the fair value of our single reporting unit with its carrying value, including goodwill. If the fair value of a reporting unit exceeds its carrying value, the reporting unit's goodwill is considered not to be impaired. If the carrying value of a reporting unit exceeds its fair value, an impairment charge is recognized in an amount equal to that excess. The impairment charge recognized is limited to the amount of goodwill present in our single reporting unit. These estimates and assumptions could have a significant impact on whether or not an impairment charge is recognized and the amount of any such charge. The Company performs its annual impairment assessment of goodwill during the fourth quarter of each fiscal year. The Company determined that there was no impairment during the prior year ended June 30, 2017.

Accounts Receivable: Accounts receivable consist primarily of amounts due to the Company from normal business activities. Accounts receivable balances are determined to be delinquent when the amount is past due based on the contractual terms with the customer. The Company maintains an allowance for doubtful accounts to reflect the likelihood of not collecting certain accounts receivable based on past collection history and specific risks identified among uncollected accounts. Accounts receivable are charged to the allowance for doubtful accounts when the Company determines that the receivable will not be collected and/or when the account has been referred to a third party collection agency. The Company has a history of minimal uncollectible accounts.

Stock-Based Compensation: Stock-based compensation cost for options and restricted stock awarded to employees and directors is measured at the grant date, based on the calculated fair value of the award and is recognized as an expense over the requisite service period (generally the vesting period of the equity grant).

Fair Value of Financial Instruments: The Company considers the fair value of all financial instruments, including cash and cash equivalents, accounts receivable and accounts payable to approximate their carrying values at September 30, 2017 and June 30, 2017 due to their short-term nature. The carrying value of the Company’s debt approximates fair value due to the market rates of interest.

SHARPS COMPLIANCE CORP. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

NOTE 4 – RECENTLY ISSUED ACCOUNTING STANDARDS

In May 2014, guidance for revenue recognition was issued which supersedes the revenue recognition requirements currently followed by the Company. The new guidance provides for a single five-step model to be applied in determining the amount and timing of the recognition of revenue related to contracts with customers. The new standard also requires additional financial statement disclosures that will enable users to understand the nature, amount, timing and uncertainty of revenue and cash flows relating to customer contracts. In March 2016, guidance for revenue from contracts with customers regarding principal versus agent considerations was issued which modified examples to assist in the application of the guidance. Companies have an option to use either a retrospective approach or cumulative effect adjustment approach to implement the standard. The guidance is effective for annual reporting periods beginning after December 15, 2017 (effective July 1, 2018 for the Company). The Company is in the initial stages of evaluating the impact that the new accounting guidance will have on its consolidated financial statements and related disclosures as well as evaluating the available transition methods. The Company will continue to evaluate the standard as well as additional changes, modifications or interpretations which may impact the Company.

In February 2016, guidance for leases was issued, which requires balance sheet recognition for rights and obligations of all leases with terms in excess of twelve months. The new guidance also requires additional disclosures about the amount, timing and uncertainty of cash flows arising from leases. The provisions of the new guidance are effective for annual periods beginning after December 15, 2018 (effective July 1, 2019 for the Company), including interim periods within the reporting period, and early application is permitted. The Company is in the initial stages of evaluating the impact of the new guidance on its consolidated financial statements and related disclosures.

NOTE 5 – INCOME TAXES

The Company’s net deferred tax assets have been fully reserved by a tax valuation allowance. The Company’s effective tax rate for the three months ended September 30, 2017 was 8.0% reflecting estimated state income taxes. The Company’s tax expense associated with taxable income during the three months ended September 30, 2017 was offset by the utilization of net operating loss carryforwards. No income tax expense was recorded for the three months ended September 30, 2016 as it was not material due to the valuation allowance and net operating losses.

NOTE 6 - NOTES PAYABLE AND LONG-TERM DEBT

On March 29, 2017, the Company entered into to a credit agreement with a commercial bank (“Credit Agreement”). The Credit Agreement, which replaced the Company’s prior credit agreement, provides for a $14.0 million credit facility, the proceeds of which may be utilized as follows: (i) $6.0 million for working capital, letters of credit (up to $2.0 million) and general corporate purposes and (ii) $8.0 million for acquisitions. Indebtedness under the Credit Agreement is secured by substantially all of the Company’s assets with advances outstanding under the working capital portion of the credit facility at any time limited to a Borrowing Base (as defined in the Credit Agreement) equal to 80% of eligible accounts receivable plus the lessor of 50% of eligible inventory and $3.0 million. Advances under the acquisition portion of the credit facility are limited to 75% of the purchase price of an acquired company and convert to a five-year term note at the time of the borrowing. Borrowings bear interest at the greater of (a) zero percent or (b) the One Month ICE LIBOR plus a LIBOR Margin of 2.5%. The LIBOR Margin may increase to as high as 3.0% depending on the Company’s cash flow leverage ratio. The interest rate as of September 30, 2017 was approximately 3.75%. The Company pays a fee of 0.25% per annum on the unused amount of the line of credit.

At September 30, 2017, long-term debt consisted of the following (in thousands):



Non-interest bearing, unsecured note payable assumed in acquisition, monthly payments of $7; maturing September 2018.	$	83

Term loan, bearing interest at 3.75%, monthly payments of $43; maturing March 2022.	2,370

Total long-term debt	2,453
Less: current portion	600
Long-term debt, net of current portion	$	1,853

The Company has availability under the Credit Agreement of $11.6 million ($6.0 million for the working capital and $5.6 million for the acquisitions) as of September 30, 2017 which may be limited by its leverage covenant. The Company also has $10,000 in letters of credit outstanding as of September 30, 2017.

SHARPS COMPLIANCE CORP. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

The Credit Agreement contains affirmative and negative covenants that, among other things, require the Company to maintain, beginning with the twelve-month period ending September 30, 2017, a maximum cash flow leverage ratio of no more than 3.5 to 1.0 and a minimum debt service coverage ratio of not less than 1.15 to 1.00. The maximum cash flow leverage ratio decreases to 3.25 to 1.0 on December 31, 2017 and to 3.0 to 1.0 on March 31, 2018. The Credit Agreement, which expires on March 29, 2019, also contains customary events of default which, if uncured, may terminate the Credit Agreement and require immediate repayment of all indebtedness to the lenders.

Payments due on long-term debt during each of the five years subsequent to September 30, 2017 are as follows (in thousands):



Twelve Months Ending September 30,
2018	$	600
2019	517
2020	517
2021	517
2022	302
	$	2,453

The Company utilizes performance bonds to support operations based on certain state requirements. At September 30, 2017, the Company had performance bonds outstanding covering financial assurance up to $0.6 million.

NOTE 7 – STOCK-BASED COMPENSATION

Stock-based compensation cost for options and restricted stock awarded to employees and directors is measured at the grant date, based on the calculated fair value of the award and is recognized as an expense over the requisite service period (generally the vesting period of the equity grant). During the three months ended September 30, 2017 and 2016, stock-based compensation amounts are as follows (in thousands):



	Three-Months Ended September 30,
	2017		2016
Stock-based compensation expense included in:
Cost of revenues	$	14	$	12
Selling, general and administrative	107		127
Total	$	121	$	139

SHARPS COMPLIANCE CORP. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

NOTE 8 - EARNINGS PER SHARE

Basic earnings per share is computed by dividing net income (loss) by the weighted average number of common shares outstanding during the period. Diluted earnings per share is computed by dividing net income (loss) by the weighted average number of common shares after considering the additional dilution related to common stock options and restricted stock. In computing diluted earnings per share, the outstanding common stock options are considered dilutive using the treasury stock method.

The Company’s restricted stock awards are treated as outstanding for earnings per share calculations since these shares have full voting rights and are entitled to participate in dividends declared on common shares, if any, and undistributed earnings. As participating securities, the shares of restricted stock are included in the calculation of basic EPS using the two-class method. For the periods presented, the amount of earnings allocated to the participating securities was not material.

The following information is necessary to calculate earnings per share for the periods presented (in thousands, except per-share data):



	Three-Months Ended September 30,
	2017		2016
Net income (loss), as reported	$	75	$	(967	)

Weighted average common shares outstanding	16,008		15,868
Effect of dilutive stock options	85		—
Weighted average diluted common shares outstanding	16,093		15,868

Net income (loss) per common share
Basic and diluted	$	0.00	$	(0.06	)

Employee stock options excluded from computation of dilutive income per share amounts because their effect would be anti-dilutive	231		145

NOTE 9 - EQUITY TRANSACTIONS

During the three months ended September 30, 2017 and 2016, stock options to purchase shares of the Company’s common stock were exercised as follows:



	Three-Months Ended September 30,
	2017		2016
Options Exercised	—		46,223
Proceeds (in thousands)	$	—	$	141
Average exercise price per share	$	—	$	3.05

As of September 30, 2017, there was $0.3 million of stock option and restricted stock compensation expense related to non-vested awards which is expected to be recognized over a weighted average period of 2.62 years.

SHARPS COMPLIANCE CORP. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

NOTE 10 – GOODWILL AND INTANGIBLE ASSETS

At September 30, 2017 and June 30, 2017, intangible assets consisted of the following (in thousands):



		September 30, 2017							June 30, 2017
	Estimated Useful Lives	Original Amount		Accumulated Amortization			Net Amount		Original Amount		Accumulated Amortization			Net Amount
Customer relationships	7 years	$	3,007	$	(597	)	$	2,410	$	3,007	$	(490	)	$	2,517
Permits	6 - 15 years	1,414		(314		)	1,100		1,373		(288		)	1,085
Patents	5 - 17 years	383		(268		)	115		383		(264		)	119
Tradename	7 years	270		(48		)	222		270		(39		)	231
Non-compete	5 years	117		(29		)	88		117		(23		)	94
Total intangible assets, net		$	5,191	$	(1,256	)	$	3,935	$	5,150	$	(1,104	)	$	4,046

During both the three months ended September 30, 2017 and 2016, amortization expense was $0.2 million. There have been no changes in the carrying amount of goodwill since June 30, 2017.

As of September 30, 2017, future amortization of intangible assets is as follows (in thousands):



Twelve Months Ending September 30,
2018	606
2019	606
2020	606
2021	599
2022	571
Thereafter	947
	$	3,935

NOTE 11 – INVENTORY

The components of inventory are as follows (in thousands):



	September 30, 2017		June 30, 2017
Raw materials	$	1,255	1,272
Finished goods	2,984		2,826
Total	$	4,239	4,098

SHARPS COMPLIANCE CORP. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

NOTE 12 – REVENUES BY SOLUTION

The components of revenues by solution are as follows (in thousands):



	Three-Months Ended September 30,
	2017		% Total		2016		% Total
REVENUES BY SOLUTION:
Mailbacks	$	5,339	55.1	%	$	6,249	65.6	%
Route-based pickup services	1,761		18.2	%	1,465		15.4	%
Unused medications	1,172		12.1	%	791		8.3	%
Third party treatment services	434		4.5	%	68		0.7	%
Other ⁽¹⁾	977		10.1	%	958		10.0	%
Total revenues	$	9,683	100.0	%	$	9,531	100.0	%


(1)	The Company’s other products include non-mailback products such as IV poles, accessories, containers, asset return boxes and other miscellaneous items.

ITEM 2.

MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

INFORMATION REGARDING FORWARD-LOOKING STATEMENTS

This quarterly report on Form 10-Q contains certain forward-looking statements and information relating to the Company and its subsidiaries that are based on the beliefs of the Company’s management as well as assumptions made by and information currently available to the Company’s management. When used in this report, the words "will," "may," "position," "plan," "potential," "continue," "anticipate," "believe," "expect," "estimate," "project" and "intend" and words or phrases of similar import, as they relate to the Company or its subsidiaries or Company management, are intended to identify forward-looking statements. Such statements reflect the known and unknown risks, uncertainties and assumptions related to certain factors, including without limitations, competitive factors, general economic conditions, customer relations, relationships with vendors, governmental regulation and supervision, seasonality, distribution networks, product introductions and acceptance, technological change, changes in industry practices, onetime events and other factors described herein. Based upon changing conditions, should any one or more of these risks or uncertainties materialize, or should any underlying assumptions prove incorrect, actual results may vary materially from those described herein as anticipated, believed, estimated, expected or intended. Consequently, no forward-looking statements can be guaranteed. When considering these forward-looking statements, you should keep in mind the risk factors and other cautionary statements in this Quarterly Report on Form 10-Q or refer to our Annual Report on Form 10-K. Actual results may vary materially. You are cautioned not to place undue reliance on any forward-looking statements. You should also understand that is not possible to predict or identify all such factors and as such should not consider the preceding list or the risk factors to be a complete list of all potential risks and uncertainties. The Company does not intend to update these forward-looking statements.

GENERAL

Sharps Compliance Corp. is a leading full-service national provider of comprehensive waste management services including medical, pharmaceutical and hazardous. Our solutions facilitate the proper collection, containment, transportation and treatment of numerous types of healthcare-related materials, including hypodermic needles, lancets and other devices or objects used to puncture or lacerate the skin, or sharps, hazardous waste and unused consumer dispensed medications and over-the-counter drugs. We serve customers in multiple markets such as home health care, retail clinics and immunizing pharmacies, pharmaceutical manufacturers, professional offices (physicians, dentists and veterinarians), assisted living and long-term care facilities (assisted living, continuing care, long-term acute care, memory care and skilled nursing), government (federal, state and local), consumers, commercial and agriculture, as well as distributors to many of the aforementioned markets. We assist our customers in determining which of our solution offerings best fit their needs for the collection, containment, return transportation and treatment of medical waste, used healthcare materials, pharmaceutical waste, hazardous waste and unused dispensed medications. Our differentiated approach provides our customers the flexibility to return and properly treat medical waste, used healthcare materials or unused dispensed medications through a variety of solutions and products transported primarily through the United States Postal Service (“USPS”). For customers with facilities or locations that may generate larger quantities of medical waste, we integrate the route-based pick-up service into our complete offering. The benefits of this comprehensive offering include single point of contact, consolidated billing, integrated manifest and proof of destruction repository in addition to our cost savings. Furthermore, we provide comprehensive tracking and reporting tools that enable our customers to meet complex medical, pharmaceutical and hazardous waste disposal and compliance requirements. We believe the fully-integrated nature of our operations is a key factor leading to our success and continued recurring revenue growth. We continue to take advantage of the many opportunities in all markets served as we educate the market place and as prospective customers become more aware of alternatives to traditional methods of disposal (i.e., route-based pick-up services).

Our key markets include healthcare facilities, pharmaceutical manufacturers, home healthcare providers, assisted living/long-term care, surgery centers, retail pharmacies and clinics and the professional market, which is comprised of physicians, dentists and veterinary practices. The Company’s flagship product, the Sharps^® Recovery System, is a comprehensive solution for the containment, transportation, treatment and tracking of medical waste and used healthcare materials. In October 2014, the Company launched MedSafe^®, a patent pending solution for the safe collection, transportation and proper disposal of unwanted and expired prescription medications including controlled substances from ultimate users. MedSafe has been designed to meet or exceed the regulations issued by the Drug Enforcement Administration (“DEA”) implementing the Secure and Responsible Drug Disposal Act of 2010 (the “Act”), which became effective October 9, 2014. In July 2015 and December 2015, the Company augmented its network of medical and hazardous waste service providers with acquisitions of route-based pickup services in the Northeast serving Pennsylvania, Maryland, Ohio and other neighboring states. Additionally, the Company now services parts of Texas and Louisiana with route-based pickup services. In July 2016, the Company acquired another route-based pickup service which expanded service to New York and New Jersey and strengthened the Company’s position in the Northeast. The Company now offers its route-based pickup services in a twenty-three (23) state region of the South, Southeast and Northeast portions of the United States. Our other solutions include TakeAway Medication Recovery System™, TakeAway Recycle System™, ComplianceTRAC^SM, Universal Waste Shipback Systems, TakeAway Environmental Return System™, SharpsTracer^®, Sharps Secure^® Needle Disposal System, Complete Needle™ Collection & Disposal System, Pitch-It IV™ Poles, Asset Return System, Sharps^® MWMS™ (a Medical Waste Management System (“MWMS”)) and Spill Kit and Recovery System.

RESULTS OF OPERATIONS

The following analyzes changes in the consolidated operating results and financial condition of the Company during the three months ended September 30, 2017 and 2016. The following table sets forth, for the periods indicated, certain items from the Company's Condensed Consolidated Statements of Operations (dollars in thousands and percentages expressed as a percentage of revenue):



	Three-Months Ended September 30,
	2017			%		2016			%
	(Unaudited)
Revenues	$	9,683		100.0	%	$	9,531		100.0	%
Cost of revenues	6,655			68.7	%	6,572			69.0	%
Gross profit	3,028			31.3	%	2,959			31.0	%
SG&A expense	2,725			28.1	%	3,699			38.8	%
Depreciation and amortization	202			2.1	%	200			2.1	%
Operating income (loss)	101			1.0	%	(940		)	(9.9	)%
Interest income	5					4
Interest expense	(24		)			(31		)
Total other expense	(19		)	(0.2	)%	(27		)	(0.3	)%
Income (loss) before income taxes	82			0.8	%	(967		)	(10.1	)%
Income tax expense	7			0.1	%	—			—	%
Net Income (loss)	$	75		0.8	%	$	(967	)	(10.1	)%

THREE MONTHS ENDED SEPTEMBER 30, 2017 AS COMPARED TO THREE MONTHS ENDED SEPTEMBER 30, 2016

Total revenues for the three months ended September 30, 2017 of $9.7 million increased by $0.2 million, or 1.6%, over the total revenues for the three months ended September 30, 2016 of $9.5 million. The increase in revenue is due to product returns on sales in prior periods in excess of current year deferred revenue. The components of billings by market are as follows (in thousands):



	Three-Months Ended September 30,
	(Unaudited)
	2017			2016			Variance
BILLINGS BY MARKET:
Professional	$	3,101		$	2,818		$	283
Home Health Care	2,001			1,866			135
Pharmaceutical Manufacturer	1,532			1,787			(255		)
Retail	1,400			2,059			(659		)
Assisted Living	604			593			11
Government	554			450			104
Environmental	434			68			366
Other	218			207			11
Subtotal	9,844			9,848			(4		)
GAAP Adjustment *	(161		)	(317		)	156
Revenue Reported	$	9,683		$	9,531		$	152

*Represents the net impact of the revenue recognition adjustment required to arrive at reported generally accepted accounting principles (“GAAP”) revenue. Customer billings include all invoiced amounts associated with products shipped or services rendered during the period reported. GAAP revenue includes customer billings as well as numerous adjustments necessary to reflect, (i) the deferral of a portion of current period sales and (ii) recognition of certain revenue associated with products returned for treatment and destruction. The difference between customer billings and GAAP revenue is reflected in the Company’s balance sheet as deferred revenue. See Note 3 “Revenue Recognition” in “Notes to Condensed Consolidated Financial Statements”.

The components of billings by solution are as follows (in thousands):



	Three-Months Ended September 30,
	2017			% Total		2016			% Total
BILLINGS BY SOLUTION:
Mailbacks	$	5,500		55.9	%	$	6,566		66.7	%
Route-based pickup services	1,761			17.9	%	1,465			14.9	%
Unused medications	1,172			11.9	%	791			8.0	%
Third party treatment services	434			4.4	%	68			0.7	%
Other ⁽¹⁾	977			9.9	%	958			9.7	%
Total billings	$	9,844		100.0	%	$	9,848		100.0	%
GAAP adjustment ⁽²⁾	(161		)			(317		)
Revenue reported	$	9,683				$	9,531


(1)	The Company’s other products include IV poles, accessories, containers, asset return boxes and other miscellaneous items.

(2)

Represents the net impact of the revenue recognition adjustment required to arrive at reported generally accepted accounting principles (“GAAP”) revenue. Customer billings include all invoiced amounts associated with products shipped or services rendered during the period reported. GAAP revenue includes customer billings as well as numerous adjustments necessary to reflect, (i) the deferral of a portion of current period sales and (ii) recognition of certain revenue associated with products returned for treatment and destruction. The difference between customer billings and GAAP revenue is reflected in the Company’s balance sheet as deferred revenue.

Billings were relatively flat compared to the prior year. Billings increased in the Environmental ($0.4 million), Professional ($0.3 million), Home Health Care ($0.1 million) and Government ($0.1 million) markets. Billings decreased in the Retail ($0.7 million) and Pharmaceutical Manufacturer ($0.3 million) markets. The increase in Environmental billings was due to higher third party treatment billings from our treatment facilities in Texas and Pennsylvania. Professional market billings reflected organic growth as the Company continued its focus on securing customers from the small to medium quantity generator sector, which consists largely of physicians, clinics, dentists, surgery centers, veterinarians and other healthcare professionals, who benefit from the cost-effective and convenient Sharps Recovery System™ and the Company’s route-based pick-up services. Home Health Care billings increased due to the timing of distributor purchases. The increase in Government billings was due to Medsafe related orders. The decrease in Retail billings was due primarily to lower flu immunization related orders and the loss of one retail pharmacy customer. The decrease in Pharmaceutical Manufacturer billings was mainly due to timing of inventory builds. Billings for Mailbacks in the three months ended September 30, 2017 decreased 16.2% to $5.5 million as compared to $6.6 million in the prior year period and represented 55.9% of total billings. Billings for Route-Based Pickup Services increased 20.2% to $1.8 million as compared to $1.5 million in the prior year period and represented 17.9% of total billings.

Cost of revenues for the three months ended September 30, 2017 of $6.7 million was 68.7% of revenues. Cost of revenues for the three months ended September 30, 2016 of $6.6 million was 69.0% of revenues. The gross margin for the three months ended September 30, 2017 of 31.3% was in line with the gross margin for the three months ended September 30, 2016 of 31.0%.

Selling, general and administrative (“SG&A”) expenses for the three months ended September 30, 2017 and 2016 were $2.7 million and $3.7 million, respectively. The three months ended September 30, 2016 included $0.7 million of one-time expenses related to the Company's acquisition of Citiwaste. Without these costs, SG&A for the first quarter of fiscal 2017 was $3.0 million. The decrease in SG&A (after excluding one-time expenses) for the three months ended September 30, 2017 of $0.3 million reflects the impact of cost savings initiatives launched in the second quarter of fiscal year 2017.

The Company reported operating income of $0.1 million for the three months ended September 30, 2017 compared to operating loss of $0.9 million for the three months ended September 30, 2016. Operating income increased mainly due to lower SG&A costs (discussed above).

The Company reported income before income taxes of $0.1 million for the three months ended September 30, 2017 versus loss before income taxes of $1.0 million for the three months ended September 30, 2016. Income before income taxes increased due to the change in operating income (discussed above).

The Company’s effective tax rate for the three months ended September 30, 2017 was 8.0% reflecting estimated state income tax payments. No income tax expense was recorded for the three months ended September 30, 2016 as it was not material due to the valuation allowance and net operating losses.

The Company reported a net income of $0.1 million for the three months ended September 30, 2017 compared to net loss of $1.0 million for the three months ended September 30, 2016. Net income increased due to the change in the operating income (discussed above).

The Company reported basic and diluted income per share of $0.00 for the three months ended September 30, 2017 versus basic and diluted loss per share of $(0.06) for the three months ended September 30, 2016. Basic and diluted income per share increased due to the change in net income (discussed above).

PROSPECTS FOR THE FUTURE

The Company continues to focus on core markets and solution offerings that fuel growth. Its key markets include healthcare facilities, pharmaceutical manufacturers, home healthcare providers, assisted living/long-term care, retail pharmacies and clinics, and the professional market which is comprised of physicians, dentists, surgery centers and veterinary practices. These markets require cost-effective services for managing medical, pharmaceutical and hazardous waste.

The Company believes its growth opportunities are supported by the following:

•

A large professional market that consists of dentists, veterinarians, clinics, private practice physicians, urgent care facilities, ambulatory surgical centers and other healthcare facilities. This regulated market consists of small to medium quantity generators of medical, pharmaceutical and hazardous waste where we can offer a lower cost to service with solutions to match individual facility needs. The Company addresses this market from two directions: (i) field sales which focus on larger-dollar and nationwide opportunities where we can integrate the route-based pickup service along with our mailback solutions to create a comprehensive medical waste management offering and (ii) inside and online sales which focus on the individual or small group professional offices, government agencies, smaller retail pharmacies and clinics and assisted living/long-term care facilities. The Company is able to compete more aggressively in the medium quantity generator market with the addition of route-based services where the mailback may not be as cost effective. The Company’s route-based business provides direct service to areas encompassing about 155 million people or 48% of the U.S. population.

•

In July 2015 and December 2015, the Company augmented its network of medical and hazardous waste service providers with acquisitions of route-based pickup services in the Northeast serving Pennsylvania, Maryland, Ohio and other neighboring states. In July 2016, the Company acquired another route-based pickup service which expanded service to New York and New Jersey and strengthened the Company’s position in the Northeast. Through a combination of acquisition and organic growth, the Company now offers route-based pickup services in a twenty-three (23) state region of the South, Southeast and Northeast portions of the United States. The Company directly serves more than 9,500 customer locations with route-based pickup services. With the addition of these route-based pickup regions and the network of medical and hazardous waste service providers servicing the entire U.S., the Company offers customers a blended product portfolio to effectively manage multi-site and multi-sized locations, including those that generate larger quantities of waste. The network has had a significant positive impact on our pipeline of sales opportunities - over 60% of this pipeline is attributable to opportunities providing comprehensive waste management service offerings where both the mailback and pickup service are integrated into the offering.

•

The changing demographics of the U.S. population – according to the U.S. Census Bureau, 2012 Population Estimates and National Projections, one out of five Americans will be 65 years or older by 2030, which will increase the need for cost-effective medical waste management solutions, especially in the long-term care and home healthcare markets. With multiple solutions for managing regulated healthcare-related waste, the Company delivers value as a single-source provider with blended mailback and route-based pickup services matched to the waste volumes of each facility.

•

The shift of healthcare from traditional settings to the retail pharmacy and clinic markets, where the Company focuses on driving increased promotion of the Sharps Recovery System. According to the Centers for Disease Control ("CDC"), 24% of flu shots for adults were administered in a retail clinic. Over the flu seasons from 2011 to 2014, the growth in the Retail flu business for Sharps was between 24% and 36%. Despite the decrease in Retail flu business for fiscal year 2017 (the 2016 flu season) of 15% due to a mild flu season and the loss of one retail pharmacy customer, Sharps believes the Retail market should continue to contribute to long-term growth for the Company as consumers increasingly use alternative sites, such as retail pharmacies, to obtain flu and other immunizations.


•	The passage of regulations for ultimate user medication disposal allows the Company to offer new solutions (MedSafe and TakeAway Medication Recovery System envelopes) that meet the regulations for ultimate user controlled substances disposal (Schedules II-V) to retail pharmacies. Additionally, with the new regulations, the Company is able to provide

the MedSafe and TakeAway Medication Recovery Systems to assisted living and hospice to address a long standing issue within long-term care.

•

Local, state and federal agencies have growing needs for solutions to manage medical and pharmaceutical waste — the Company's Sharps Recovery System is ideal for as-needed disposal of sharps and other small quantities of medical waste generated within government buildings, schools and communities. The Company also provides TakeAway Medication Recovery System envelopes and MedSafe solutions to government agencies in need of proper and regulatory compliant medication disposal.

•

With an increased number of self-injectable medication treatments and local regulations, the Company believes its flagship product, the Sharps Recovery System, continues to offer the best option for proper sharps disposal at an affordable price. The Company delivers comprehensive services to pharmaceutical manufacturers that sell high-dollar, self-injectable medications, which include data management, compliance reporting, fulfillment, proper containment with disposal, branding and conformity with applicable regulations. In addition, the Company provides self-injectors with online and retail purchase options of sharps mailback systems, such as the Sharp Recovery System and Complete Needle Collection & Disposal System, respectively.


•	A heightened interest by many commercial companies who are looking to improve workplace safety with proper sharps disposal and unused medication disposal solutions — the Company offers a variety of services to meet these needs, including the Sharps Secure Needle Disposal System, Sharps Recovery System, Spill Kits and TakeAway Medication Recovery System envelopes.

•

The Company continually develops new solution offerings such as ultimate user medication disposal (MedSafe and TakeAway Medication Recovery System), mailback services for DEA registrant expired inventory of controlled substances (TakeAway Medication Recovery System DEA Reverse Distribution for Registrants) and shipback services for collection and recycling of single-use medical devices from surgical centers and other healthcare facilities (TakeAway Recycle System).


•	The Company’s strong financial position with a cash balance of $5.2 million and debt of $2.5 million and additional availability under the Credit Agreement as of September 30, 2017.

LIQUIDITY AND CAPITAL RESOURCES

Cash Flow

Cash flow has historically been primarily influenced by demand for products and services, operating margins and related working capital needs as well as more strategic activities including acquisitions, stock repurchases and fixed asset additions. Cash and cash equivalents increased by $0.5 million to $5.2 million at September 30, 2017 from $4.7 million at June 30, 2017 due to the following:


•	Cash Flows from Operating Activities - Working capital increased by $0.3 million to $10.8 million at September 30, 2017 from $10.5 million at June 30, 2017. The increase in working capital is primarily attributed to an increase in cash and cash equivalents and:


•	a decrease in accounts receivable of $0.3 million to $7.3 million at September 30, 2017 from $7.6 million at June 30, 2017 due to timing of billings and collections.


•	an increase in inventory of $0.1 million to $4.2 million at September 30, 2017 from $4.1 million at June 30, 2017. The increase in inventory is due to timing of sales and adjustment of inventory levels to facilitate customer orders.


•	a decrease in prepaid and other current assets of $0.1 million to $0.6 million at September 30, 2017 from $0.7 million at June 30, 2017.


•	Cash Flows used in Investing Activities - Investing activities include capital expenditures of $0.2 million.


•	Cash Flows used in Financing Activities – Financing activities include repayments of debt of $0.2 million.

Off-Balance Sheet Arrangements

The Company was not a party to any off-balance sheet transactions as defined in Item 303 of Regulation S-K for the three months ended September 30, 2017 and the year ended June 30, 2017.

Credit Facility

On March 29, 2017, the Company entered into to a credit agreement with a commercial bank (“Credit Agreement”). The Credit Agreement, which replaced the Company’s prior credit agreement, provides for a $14.0 million credit facility, the proceeds of which may be utilized as follows: (i) $6.0 million for working capital, letters of credit (up to $2.0 million) and general corporate purposes and (ii) $8.0 million for acquisitions. Indebtedness under the Credit Agreement is secured by substantially all of the Company’s assets with advances outstanding under the working capital portion of the credit facility at any time limited to a Borrowing Base (as defined in the Credit Agreement) equal to 80% of eligible accounts receivable plus the lessor of 50% of eligible inventory and $3 million. Advances under the acquisition portion of the credit facility are limited to 75% of the purchase price of an acquired company and convert to a five-year term note at the time of the borrowing. Borrowings bear interest at the greater of (a) zero percent or (b) the One Month ICE LIBOR plus a LIBOR Margin of 2.5%. The LIBOR Margin may increase to as high as 3.0% depending on the Company’s cash flow leverage ratio. The interest rate as of September 30, 2017 was approximately 3.75%. The Company pays a fee of 0.25% per annum on the unused amount of credit facility. At September 30, 2017, $2.4 million was outstanding related to the acquisition portion of the credit facility and $0.1 million related to the unsecured note payable assumed in acquisition. No amounts were outstanding under the working capital portion of the credit facility at September 30, 2017.

The Company has availability under the Credit Agreement of approximately $11.6 million ($6.0 million for the working capital and $5.6 million for the acquisitions) as of September 30, 2017 which may be limited by its leverage covenant. The Company also had $10 thousand in letters of credit outstanding as of September 30, 2017.

Management believes that the Company’s current cash resources (cash on hand) will be sufficient to fund operations for the twelve months ending November 1, 2018.

CRITICAL ACCOUNTING POLICIES

Revenue Recognition: The Company recognizes revenue when services are provided and from product sales when (i) goods are shipped or delivered and title and risk of loss pass to the customer, (ii) the price is substantially fixed or determinable and (iii) collectability is reasonably assured except for those sales via multiple-deliverable arrangements. Provisions for certain rebates, product returns and discounts to customers are accounted for as reductions in sales in the same period the related sales are recorded. Product discounts granted are based on the terms of arrangements with direct, indirect and other market participants, as well as market conditions, including prices charged by competitors. Rebates are estimated based on contractual terms, historical experience, trend analysis and projected market conditions in the various markets served. Service agreements which include a vendor managed inventory program include terms that meet the “bill and hold” criteria and as such are recognized when the order is completed, at which point title has transferred, there are no acceptance provisions and amounts are segregated in the Company’s warehouse.

Certain products offered by the Company have revenue producing components that are recognized over multiple delivery points (Sharps Recovery System™ and various other solutions like the Takeaway Medication Recovery Systems, referred to as “Mailbacks” and Sharps^® Pump and Asset Return Boxes, referred to as “Pump Returns”) and can consist of up to three separate elements, or units of measure, as follows: (1) the sale of the compliance and container system, (2) return transportation and (3) treatment service. In accordance with the relative selling price methodology, an estimated selling price is determined for all deliverables that qualify for separate units of accounting. The actual consideration received in a multiple-deliverable arrangement is then allocated to the units based on their relative sales price. The selling price for the transportation revenue and the treatment revenue utilizes third party evidence. The Company estimates the selling price of the compliance and container system based

on the product and services provided including compliance with local, state and federal laws, adherence to stringent manufacturing and testing requirements, safety to the patient and the community as well as storage and containment capabilities.

Income Taxes: Deferred tax assets and liabilities are determined based on differences between financial reporting and tax bases of assets and liabilities and are measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse. A valuation allowance is established when it is more likely than not that some portion or all of the deferred tax assets will not be realized. The establishment of valuation allowances and development of projected annual effective tax rates requires significant judgment and is impacted by various estimates. Both positive and negative evidence, as well as the objectivity and verifiability of that evidence, is considered in determining the appropriateness of recording a valuation allowance on deferred tax assets. Under GAAP, the valuation allowance has been recorded to reduce our deferred tax assets to an amount that is more likely than not to be realized and is based upon the uncertainty of the realization of certain federal and state deferred tax assets related to net operating loss carryforwards and other tax attributes.

RECENTLY ISSUED ACCOUNTING STANDARDS

ITEM 4. CONTROLS AND PROCEDURES

Evaluation of Disclosure Controls and Procedures

The Company maintains “disclosure controls and procedures,” as such term is defined in Rule 13a-15(e) under the Exchange Act, that are designed to ensure that information required to be disclosed in our Exchange Act reports is recorded, processed, summarized and reported within the time periods specified in the SEC rules and forms, and that such information is accumulated and communicated to management, including the Chief Executive Officer (“CEO”) and the Chief Financial Officer (“CFO”) as appropriate, to allow timely decisions regarding required disclosure. The Company conducted an evaluation (the “Evaluation”), under the supervision and with the participation of the CEO and CFO, of the effectiveness of the design and operation of our disclosure controls and procedures (“Disclosure Controls”) as of September 30, 2017, pursuant to Rules 13a-15(e) and 15d-15(e) of the Exchange Act. Based upon this Evaluation, the CEO and CFO concluded that our Disclosure Controls were effective as of September 30, 2017.

Changes in Internal Control

During the three months ended September 30, 2017, there were no changes in the Company’s internal controls over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) of the Exchange Act), that have materially affected, or are reasonably likely to materially affect the Company’s internal control over financial reporting.

PART II – OTHER INFORMATION

ITEM 1. LEGAL PROCEEDINGS

From time to time, the Company is involved in legal proceedings and litigation in the ordinary course of business. In the opinion of management, the outcome of such matters will not have a material adverse effect on the Company’s consolidated financial position or consolidated results of operations.

ITEM 1A. RISK FACTORS

Refer to Item 1A. Risk Factors in the Company’s annual report on Form 10-K for the year ended June 30, 2017 for the Company’s risk factors. During the period ended September 30, 2017, there have been no changes to the Company’s risk factors.

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS.

None

ITEM 6. EXHIBITS



(a)	Exhibits:

31.1	Certification of Chief Executive Officer in accordance with Section 302 of the Sarbanes-Oxley Act (filed herewith)

31.2	Certification of Chief Financial Officer in accordance with Section 302 of the Sarbanes-Oxley Act (filed herewith)

32.1	Certification of Chief Executive Officer in accordance with Section 906 of the Sarbanes-Oxley Act (filed herewith)

32.2	Certification of Chief Financial Officer in accordance with Section 906 of the Sarbanes-Oxley Act (filed herewith)

101.INS	XBRL Instance Document (filed herewith)

101.SCH	XBRL Taxonomy Extension Schema Document (filed herewith)

101.CAL	XBRL Taxonomy Extension Calculation Linkbase Document (filed herewith)

101.DEF	XBRL Taxonomy Extension Linkbase Document (filed herewith)

101.LAB	XBRL Taxonomy Extension Label Linkbase Document (filed herewith)

101.PRE	XBRL Taxonomy Extension Presentation Linkbase Document (filed herewith)

ITEMS 3, 4 AND 5 ARE NOT APPLICABLE AND HAVE BEEN OMITTED.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.



	REGISTRANT:
	SHARPS COMPLIANCE CORP.

Dated: November 1, 2017	By: /s/ DAVID P. TUSA
	David P. Tusa
	Chief Executive Officer and President
	(Principal Executive Officer)



Dated: November 1, 2017	By: /s/ DIANA P. DIAZ
	Diana P. Diaz
	Vice President and Chief Financial Officer
	(Principal Financial and Accounting Officer)

EX-31.1 2 exhibit311.htm EXHIBIT 31.1 Exhibit

Exhibit 31.1

CERTIFICATION OF CHIEF EXECUTIVE OFFICER

IN ACCORDANCE WITH SECTION 302 OF THE SARBANES-OXLEY ACT

I, David P. Tusa, certify that:


1.	I have reviewed this quarterly report on Form 10-Q of Sharps Compliance Corp.;


2.	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;


3.	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;


4.	The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:


(a)	Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;


(b)	Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;


(c)	Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and


(d)	Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and


5.	The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal controls over financial reporting.



Date: November 1, 2017	/s/David P. Tusa
	Chief Executive Officer and President
	(Principal Executive Officer)

EX-31.2 3 exhibit312.htm EXHIBIT 31.2 Exhibit

Exhibit 31.2

CERTIFICATION OF CHIEF FINANCIAL OFFICER

IN ACCORDANCE WITH SECTION 302 OF THE SARBANES-OXLEY ACT

I, Diana P. Diaz, certify that:


1.	I have reviewed this quarterly report on Form 10-Q of Sharps Compliance Corp.;


2.	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;


3.	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;


4.	The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:


(a)	Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;


(b)	Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;


(c)	Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and


(d)	Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and


5.	The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal controls over financial reporting.



Date: November 1, 2017	/s/Diana P. Diaz
	Vice President and Chief Financial Officer
	(Principal Financial and Accounting Officer)

EX-32.1 4 exhibit321.htm EXHIBIT 32.1 Exhibit

Exhibit 32.1

CERTIFICATION OF CHIEF EXECUTIVE OFFICER

IN ACCORDANCE WITH SECTION 906 OF THE SARBANES-OXLEY ACT

In connection with the quarterly report of Sharps Compliance Corp. (the “Company”) on Form 10-Q for the period ended September 30, 2017, as filed with the Securities and Exchange Commission on the date hereof, I, David P. Tusa, Chief Executive Officer and President of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, to the best of my knowledge that:


(1)	The Form 10-Q report for the period ended September 30, 2017, filed with the Securities and Exchange Commission on November 1, 2017 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and


(2)	The information contained in the Form 10-Q report for the period ended September 30, 2017 fairly presents, in all material respects, the financial condition and results of operations of Sharps Compliance Corp.



Date: November 1, 2017	/s/David P. Tusa
	Chief Executive Officer and President

EX-32.2 5 exhibit322.htm EXHIBIT 32.2 Exhibit

Exhibit 32.2

CERTIFICATION OF CHIEF FINANCIAL OFFICER

IN ACCORDANCE WITH SECTION 906 OF THE SARBANES-OXLEY ACT

In connection with the quarterly report of Sharps Compliance Corp. (the “Company”) on Form 10-Q for the period ended September 30, 2017, as filed with the Securities and Exchange Commission on the date hereof, I, Diana P. Diaz, Vice President and Chief Financial Officer, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, to the best of my knowledge that:


(1)	The Form 10-Q report for the period ended September 30, 2017, filed with the Securities and Exchange Commission on November 1, 2017 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and


(2)	The information contained in the Form 10-Q report for the period ended September 30, 2017 fairly presents, in all material respects, the financial condition and results of operations of Sharps Compliance Corp.



Date: November 1, 2017	/s/Diana P. Diaz
	Vice President and Chief Financial Officer

EX-101.INS 6 smed-20170930.xml XBRL INSTANCE DOCUMENT 0000898770 2017-07-01 2017-09-30 0000898770 2017-10-30 0000898770 2017-06-30 0000898770 2017-09-30 0000898770 2016-07-01 2016-09-30 0000898770 us-gaap:RetainedEarningsMember 2017-07-01 2017-09-30 0000898770 2016-07-01 2017-06-30 0000898770 us-gaap:CommonStockMember 2016-06-30 0000898770 us-gaap:RetainedEarningsMember 2016-06-30 0000898770 us-gaap:AdditionalPaidInCapitalMember 2016-07-01 2017-06-30 0000898770 us-gaap:CommonStockMember 2017-06-30 0000898770 2016-06-30 0000898770 us-gaap:TreasuryStockMember 2017-09-30 0000898770 us-gaap:RetainedEarningsMember 2017-06-30 0000898770 us-gaap:AdditionalPaidInCapitalMember 2016-06-30 0000898770 us-gaap:TreasuryStockMember 2016-06-30 0000898770 us-gaap:AdditionalPaidInCapitalMember 2017-09-30 0000898770 us-gaap:TreasuryStockMember 2017-06-30 0000898770 us-gaap:AdditionalPaidInCapitalMember 2017-06-30 0000898770 us-gaap:CommonStockMember 2016-07-01 2017-06-30 0000898770 us-gaap:RetainedEarningsMember 2016-07-01 2017-06-30 0000898770 us-gaap:RetainedEarningsMember 2017-09-30 0000898770 us-gaap:CommonStockMember 2017-09-30 0000898770 us-gaap:AdditionalPaidInCapitalMember 2017-07-01 2017-09-30 0000898770 2016-09-30 0000898770 smed:CreditAgreementMember us-gaap:MaximumMember 2017-07-01 2017-09-30 0000898770 smed:CreditAgreementMember us-gaap:LondonInterbankOfferedRateLIBORMember 2017-07-01 2017-09-30 0000898770 smed:CreditAgreementMember 2017-07-01 2017-09-30 0000898770 smed:CreditAgreementMember us-gaap:MinimumMember 2017-07-01 2017-09-30 0000898770 us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember smed:CreditAgreementMember 2017-09-30 0000898770 smed:WorkingCapitalMember smed:CreditAgreementMember 2017-09-30 0000898770 smed:TermLoanMember 2017-09-30 0000898770 us-gaap:LetterOfCreditMember smed:CreditAgreementMember 2017-09-30 0000898770 us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember smed:CreditAgreementMember 2017-07-01 2017-09-30 0000898770 smed:CreditAgreementMember us-gaap:MaximumMember us-gaap:LondonInterbankOfferedRateLIBORMember 2017-07-01 2017-09-30 0000898770 us-gaap:SuretyBondMember 2017-09-30 0000898770 smed:TermLoanMember 2017-07-01 2017-09-30 0000898770 smed:CreditAgreementMember 2017-09-30 0000898770 us-gaap:UnsecuredDebtMember 2017-09-30 0000898770 us-gaap:UnsecuredDebtMember 2017-07-01 2017-09-30 0000898770 us-gaap:CostOfSalesMember 2017-07-01 2017-09-30 0000898770 us-gaap:CostOfSalesMember 2016-07-01 2016-09-30 0000898770 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2017-07-01 2017-09-30 0000898770 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2016-07-01 2016-09-30 0000898770 us-gaap:ConstructionPermitsMember 2017-09-30 0000898770 us-gaap:PatentsMember 2017-09-30 0000898770 us-gaap:NoncompeteAgreementsMember 2017-07-01 2017-09-30 0000898770 us-gaap:ConstructionPermitsMember 2017-06-30 0000898770 us-gaap:CustomerRelationshipsMember 2017-07-01 2017-09-30 0000898770 us-gaap:NoncompeteAgreementsMember 2017-06-30 0000898770 us-gaap:TradeNamesMember 2017-09-30 0000898770 us-gaap:PatentsMember 2017-06-30 0000898770 us-gaap:CustomerRelationshipsMember 2017-09-30 0000898770 us-gaap:CustomerRelationshipsMember 2017-06-30 0000898770 us-gaap:TradeNamesMember 2017-06-30 0000898770 us-gaap:NoncompeteAgreementsMember 2017-09-30 0000898770 us-gaap:TradeNamesMember 2017-07-01 2017-09-30 0000898770 us-gaap:PatentsMember us-gaap:MinimumMember 2017-07-01 2017-09-30 0000898770 us-gaap:ConstructionPermitsMember us-gaap:MinimumMember 2017-07-01 2017-09-30 0000898770 us-gaap:ConstructionPermitsMember us-gaap:MaximumMember 2017-07-01 2017-09-30 0000898770 us-gaap:PatentsMember us-gaap:MaximumMember 2017-07-01 2017-09-30 0000898770 smed:UnusedMedicationsMember 2016-07-01 2016-09-30 0000898770 smed:ThirdPartyTreatmentServicesMember 2016-07-01 2016-09-30 0000898770 smed:MailbacksMember 2016-07-01 2016-09-30 0000898770 smed:ThirdPartyTreatmentServicesMember 2017-07-01 2017-09-30 0000898770 smed:RouteBasedPickupServicesMember 2016-07-01 2016-09-30 0000898770 us-gaap:AllOtherSegmentsMember 2016-07-01 2016-09-30 0000898770 us-gaap:AllOtherSegmentsMember 2017-07-01 2017-09-30 0000898770 smed:MailbacksMember 2017-07-01 2017-09-30 0000898770 smed:UnusedMedicationsMember 2017-07-01 2017-09-30 0000898770 smed:RouteBasedPickupServicesMember 2017-07-01 2017-09-30 xbrli:shares iso4217:USD xbrli:shares xbrli:pure smed:state_region iso4217:USD false --06-30 Q1 2018 2017-09-30 10-Q 0000898770 16008412 Smaller Reporting Company SHARPS COMPLIANCE CORP 2700000 2900000 3000000 3.50 3.25 3.0 P1M 1.15 1889000 0 310000 21000 23 0.8 0.5 0.75 1000000 1000000 34000 69000 140000 0

1710000

1978000

7553000

7279000

1800000

1518000

28063000

28184000

496000

121000

78000

80000

200000

145000

231000

34464000

34527000

17020000

17244000

12435000

6908000

4675000

5160000

-5527000

485000

0.01

20000000

16304027

16008412

163000

0.656

0.154

0.007

0.083

0.100

0.551

0.182

0.045

0.121

0.101

6572000

6655000

0.030

0.025

43000

7000

P5Y

2421000

2396000

478000

528000

200000

202000

338000

390000

-0.06

0.00

0.080

300000

P2Y7M15D

P15Y

P6Y

P7Y

P5Y

P17Y

P5Y

P7Y

1104000

288000

490000

23000

264000

39000

1256000

314000

597000

29000

268000

48000

947000

606000

571000

599000

606000

5150000

1373000

3007000

117000

383000

270000

5191000

1414000

3007000

117000

383000

270000

4046000

1085000

2517000

94000

119000

231000

3935000

1100000

2410000

88000

115000

222000

-6000

2000

6735000

2959000

3028000

600000.0

-967000

82000

7000

3000

644000

-29000

772000

-274000

285000

25000

252000

72000

213000

-126000

85000

31000

24000

22000

17000

2826000

2984000

4098000

4239000

1272000

1255000

4000

5000

9177000

9044000

34464000

34527000

6532000

6492000

10000

0.0375

6000000.0

2000000.0

8000000.0

14000000.0

6000000

5600000

11600000

0.0025

2453000

2370000

83000

601000

600000

302000

517000

600000

2002000

1853000

3120000

-150000

-7855000

-273000

-792000

908000

-967000

-1293000

75000

-27000

-19000

-940000

101000

120000

122000

165000

171000

7062000

41000

806000

235000

694000

566000

141000

3000000

13000

3000

141000

6543000

6491000

21000

150000

-1385000

-1310000

9531000

6249000

1465000

68000

791000

958000

5339000

1761000

434000

1172000

977000

9683000

3699000

2725000

139000

12000

127000

14000

107000

121000

3.05

15740458

295615

16304027

295615

16304027

295615

415527

52992

46223

95050

1899000

1895000

4000

342000

341000

1000

23843000

25331000

158000

-92000

-1554000

25287000

28063000

163000

-1385000

-1554000

25483000

28184000

163000

-1310000

-1554000

295615

1554000

15868000

16093000

15868000

16008000

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">BASIS OF PRESENTATION</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with the rules and regulations of the Securities and Exchange Commission (“SEC”) for interim financial information and with instructions to Form 10-Q and, accordingly, do not include all information and footnotes required under generally accepted accounting principles in the United States of America ("GAAP") for complete financial statements. Additionally, the preparation of the condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect reported amounts. In the opinion of management, these interim condensed consolidated financial statements contain all adjustments (consisting of normal recurring adjustments) considered necessary for a fair presentation of the consolidated financial position of the Company as of </font><font style="font-family:inherit;font-size:10pt;">September 30, 2017</font><font style="font-family:inherit;font-size:10pt;">, the results of its operations for the </font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;">September 30, 2017</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2016</font><font style="font-family:inherit;font-size:10pt;">, cash flows for the </font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;">September 30, 2017</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2016</font><font style="font-family:inherit;font-size:10pt;"> and stockholders’ equity for the </font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;">September 30, 2017</font><font style="font-family:inherit;font-size:10pt;">. The results of operations for the </font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;">September 30, 2017</font><font style="font-family:inherit;font-size:10pt;"> are not necessarily indicative of the results to be expected for the entire fiscal year ending </font><font style="font-family:inherit;font-size:10pt;">June 30, 2018</font><font style="font-family:inherit;font-size:10pt;">. These unaudited condensed consolidated financial statements should be read in conjunction with the Company’s Annual Report on Form 10-K for the year ended </font><font style="font-family:inherit;font-size:10pt;">June 30, 2017</font><font style="font-family:inherit;font-size:10pt;">.</font></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Payments due on long-term debt during each of the five years subsequent to </font><font style="font-family:inherit;font-size:10pt;">September 30, 2017</font><font style="font-family:inherit;font-size:10pt;"> are as follows (in thousands):</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4" rowspan="1"></td></tr><tr><td style="width:89%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Twelve Months Ending September 30,</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">600</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2019</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">517</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2020</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">517</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2021</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">517</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2022</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">302</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,453</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">NOTES PAYABLE AND LONG-TERM DEBT</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On March 29, 2017, the Company entered into to a credit agreement with a commercial bank (“Credit Agreement”). The Credit Agreement, which replaced the Company’s prior credit agreement, provides for a </font><font style="font-family:inherit;font-size:10pt;">$14.0 million</font><font style="font-family:inherit;font-size:10pt;"> credit facility, the proceeds of which may be utilized as follows: (i) </font><font style="font-family:inherit;font-size:10pt;">$6.0 million</font><font style="font-family:inherit;font-size:10pt;"> for working capital, letters of credit (up to </font><font style="font-family:inherit;font-size:10pt;">$2.0 million</font><font style="font-family:inherit;font-size:10pt;">) and general corporate purposes and (ii) </font><font style="font-family:inherit;font-size:10pt;">$8.0 million</font><font style="font-family:inherit;font-size:10pt;"> for acquisitions. Indebtedness under the Credit Agreement is secured by substantially all of the Company’s assets with advances outstanding under the working capital portion of the credit facility at any time limited to a Borrowing Base (as defined in the Credit Agreement) equal to </font><font style="font-family:inherit;font-size:10pt;">80%</font><font style="font-family:inherit;font-size:10pt;"> of eligible accounts receivable plus the lessor of </font><font style="font-family:inherit;font-size:10pt;">50%</font><font style="font-family:inherit;font-size:10pt;"> of eligible inventory and </font><font style="font-family:inherit;font-size:10pt;">$3.0 million</font><font style="font-family:inherit;font-size:10pt;">. Advances under the acquisition portion of the credit facility are limited to </font><font style="font-family:inherit;font-size:10pt;">75%</font><font style="font-family:inherit;font-size:10pt;"> of the purchase price of an acquired company and convert to a </font><font style="font-family:inherit;font-size:10pt;">five</font><font style="font-family:inherit;font-size:10pt;">-year term note at the time of the borrowing. Borrowings bear interest at the greater of (a) </font><font style="font-family:inherit;font-size:10pt;">zero</font><font style="font-family:inherit;font-size:10pt;"> percent or (b) the </font><font style="font-family:inherit;font-size:10pt;">One</font><font style="font-family:inherit;font-size:10pt;"> Month ICE LIBOR plus a LIBOR Margin of </font><font style="font-family:inherit;font-size:10pt;">2.5%</font><font style="font-family:inherit;font-size:10pt;">. The LIBOR Margin may increase to as high as </font><font style="font-family:inherit;font-size:10pt;">3.0%</font><font style="font-family:inherit;font-size:10pt;"> depending on the Company’s cash flow leverage ratio.  The interest rate as of </font><font style="font-family:inherit;font-size:10pt;">September 30, 2017</font><font style="font-family:inherit;font-size:10pt;"> was approximately </font><font style="font-family:inherit;font-size:10pt;">3.75%</font><font style="font-family:inherit;font-size:10pt;">. The Company pays a fee of </font><font style="font-family:inherit;font-size:10pt;">0.25%</font><font style="font-family:inherit;font-size:10pt;"> per annum on the unused amount of the line of credit.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">At </font><font style="font-family:inherit;font-size:10pt;">September 30, 2017</font><font style="font-family:inherit;font-size:10pt;">, long-term debt consisted of the following (in thousands):</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4" rowspan="1"></td></tr><tr><td style="width:89%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Non-interest bearing, unsecured note payable assumed in acquisition, monthly payments of $7; maturing September 2018.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">83</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Term loan, bearing interest at 3.75%, monthly payments of $43; maturing March 2022.</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,370</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total long-term debt</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,453</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Less: current portion</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">600</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Long-term debt, net of current portion</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,853</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company has availability under the Credit Agreement of </font><font style="font-family:inherit;font-size:10pt;">$11.6 million</font><font style="font-family:inherit;font-size:10pt;"> (</font><font style="font-family:inherit;font-size:10pt;">$6.0 million</font><font style="font-family:inherit;font-size:10pt;"> for the working capital and </font><font style="font-family:inherit;font-size:10pt;">$5.6 million</font><font style="font-family:inherit;font-size:10pt;"> for the acquisitions) as of </font><font style="font-family:inherit;font-size:10pt;">September 30, 2017</font><font style="font-family:inherit;font-size:10pt;"> which may be limited by its leverage covenant. The Company also has </font><font style="font-family:inherit;font-size:10pt;">$10,000</font><font style="font-family:inherit;font-size:10pt;"> in letters of credit outstanding as of </font><font style="font-family:inherit;font-size:10pt;">September 30, 2017</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Credit Agreement contains affirmative and negative covenants that, among other things, require the Company to maintain, beginning with the twelve-month period ending September 30, 2017, a maximum cash flow leverage ratio of no more than </font><font style="font-family:inherit;font-size:10pt;">3.5</font><font style="font-family:inherit;font-size:10pt;"> to 1.0 and a minimum debt service coverage ratio of not less than </font><font style="font-family:inherit;font-size:10pt;">1.15</font><font style="font-family:inherit;font-size:10pt;"> to 1.00. The maximum cash flow leverage ratio decreases to </font><font style="font-family:inherit;font-size:10pt;">3.25</font><font style="font-family:inherit;font-size:10pt;"> to 1.0 on December 31, 2017 and to </font><font style="font-family:inherit;font-size:10pt;">3.0</font><font style="font-family:inherit;font-size:10pt;"> to 1.0 on March 31, 2018. The Credit Agreement, which expires on </font><font style="font-family:inherit;font-size:10pt;">March 29, 2019</font><font style="font-family:inherit;font-size:10pt;">, also contains customary events of default which, if uncured, may terminate the Credit Agreement and require immediate repayment of all indebtedness to the lenders.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Payments due on long-term debt during each of the five years subsequent to </font><font style="font-family:inherit;font-size:10pt;">September 30, 2017</font><font style="font-family:inherit;font-size:10pt;"> are as follows (in thousands):</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4" rowspan="1"></td></tr><tr><td style="width:89%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Twelve Months Ending September 30,</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">600</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2019</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">517</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2020</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">517</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2021</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">517</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2022</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">302</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,453</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company utilizes performance bonds to support operations based on certain state requirements. At </font><font style="font-family:inherit;font-size:10pt;">September 30, 2017</font><font style="font-family:inherit;font-size:10pt;">, the Company had performance bonds outstanding covering financial assurance up to </font><font style="font-family:inherit;font-size:10pt;">$0.6 million</font><font style="font-family:inherit;font-size:10pt;">.</font></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">RECENTLY ISSUED ACCOUNTING STANDARDS</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In May 2014, guidance for revenue recognition was issued which supersedes the revenue recognition requirements currently followed by the Company. The new guidance provides for a single five-step model to be applied in determining the amount and timing of the recognition of revenue related to contracts with customers. The new standard also requires additional financial statement disclosures that will enable users to understand the nature, amount, timing and uncertainty of revenue and cash flows relating to customer contracts. In March 2016, guidance for revenue from contracts with customers regarding principal versus agent considerations was issued which modified examples to assist in the application of the guidance. Companies have an option to use either a retrospective approach or cumulative effect adjustment approach to implement the standard. The guidance is effective for annual reporting periods beginning after December 15, 2017 (effective July 1, 2018 for the Company). The Company is in the initial stages of evaluating the impact that the new accounting guidance will have on its consolidated financial statements and related disclosures as well as evaluating the available transition methods. The Company will continue to evaluate the standard as well as additional changes, modifications or interpretations which may impact the Company.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In February 2016, guidance for leases was issued, which requires balance sheet recognition for rights and obligations of all leases with terms in excess of twelve months. The new guidance also requires additional disclosures about the amount, timing and uncertainty of cash flows arising from leases. The provisions of the new guidance are effective for annual periods beginning after December 15, 2018 (effective July 1, 2019 for the Company), including interim periods within the reporting period, and early application is permitted. The Company is in the initial stages of evaluating the impact of the new guidance on its consolidated financial statements and related disclosures.</font></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">STOCK-BASED COMPENSATION</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Stock-based compensation cost for options and restricted stock awarded to employees and directors is measured at the grant date, based on the calculated fair value of the award and is recognized as an expense over the requisite service period (generally the vesting period of the equity grant).  During the </font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;">September 30, 2017</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2016</font><font style="font-family:inherit;font-size:10pt;">, stock-based compensation amounts are as follows (in thousands):</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="9" rowspan="1"></td></tr><tr><td style="width:76%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Three-Months Ended<br clear="none"/>September 30,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:2px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:2px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2016</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Stock-based compensation expense included in:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cost of revenues</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">14</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Selling, general and administrative</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">107</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">127</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">121</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">139</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">EARNINGS PER SHARE</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Basic earnings per share is computed by dividing net income (loss) by the weighted average number of common shares outstanding during the period. Diluted earnings per share is computed by dividing net income (loss) by the weighted average number of common shares after considering the additional dilution related to common stock options and restricted stock. In computing diluted earnings per share, the outstanding common stock options are considered dilutive using the treasury stock method.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company’s restricted stock awards are treated as outstanding for earnings per share calculations since these shares have full voting rights and are entitled to participate in dividends declared on common shares, if any, and undistributed earnings. As participating securities, the shares of restricted stock are included in the calculation of basic EPS using the two-class method. For the periods presented, the amount of earnings allocated to the participating securities was not material.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following information is necessary to calculate earnings per share for the periods presented (in thousands, except per-share data):</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="9" rowspan="1"></td></tr><tr><td style="width:76%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Three-Months Ended<br clear="none"/>September 30,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:2px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:2px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2016</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net income (loss), as reported</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">75</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(967</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Weighted average common shares outstanding</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16,008</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15,868</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Effect of dilutive stock options</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">85</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Weighted average diluted common shares outstanding</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16,093</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15,868</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net income (loss) per common share</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Basic and diluted</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.00</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.06</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Employee stock options excluded from computation of dilutive income per share amounts because their effect would be anti-dilutive</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">231</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">145</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">Fair Value of Financial Instruments</font><font style="font-family:inherit;font-size:10pt;">: The Company considers the fair value of all financial instruments, including cash and cash equivalents, accounts receivable and accounts payable to approximate their carrying values at </font><font style="font-family:inherit;font-size:10pt;">September 30, 2017</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">June 30, 2017</font><font style="font-family:inherit;font-size:10pt;"> due to their short-term nature. The carrying value of the Company’s debt approximates fair value due to the market rates of interest.</font></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">GOODWILL AND INTANGIBLE ASSETS</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">At </font><font style="font-family:inherit;font-size:10pt;">September 30, 2017</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">June 30, 2017</font><font style="font-family:inherit;font-size:10pt;">, intangible assets consisted of the following (in thousands):</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="27" rowspan="1"></td></tr><tr><td style="width:21%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:7%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:6%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:7%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:6%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">September 30, 2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">June 30, 2017</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Estimated<br clear="none"/>Useful Lives</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Original</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Amount</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Accumulated</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Amortization</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Net</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Amount</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Original</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Amount</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Accumulated</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Amortization</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Net</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Amount</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Customer relationships</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7 years</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,007</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(597</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,410</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,007</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(490</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,517</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Permits</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6 - 15 years</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,414</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(314</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,100</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,373</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(288</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,085</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Patents</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5 - 17 years</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">383</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(268</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">115</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">383</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(264</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">119</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Tradename</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7 years</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">270</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(48</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">222</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">270</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(39</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">231</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Non-compete</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5 years</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">117</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(29</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">88</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">117</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(23</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">94</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total intangible assets, net</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,191</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,256</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,935</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,150</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,104</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,046</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">During both the </font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;">September 30, 2017</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2016</font><font style="font-family:inherit;font-size:10pt;">, amortization expense was </font><font style="font-family:inherit;font-size:10pt;">$0.2 million</font><font style="font-family:inherit;font-size:10pt;">. There have been </font><font style="font-family:inherit;font-size:10pt;">no</font><font style="font-family:inherit;font-size:10pt;"> changes in the carrying amount of goodwill since </font><font style="font-family:inherit;font-size:10pt;">June 30, 2017</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As of </font><font style="font-family:inherit;font-size:10pt;">September 30, 2017</font><font style="font-family:inherit;font-size:10pt;">, future amortization of intangible assets is as follows (in thousands):</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4" rowspan="1"></td></tr><tr><td style="width:80%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:18%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Twelve Months Ending September 30,</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2018</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">606</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2019</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">606</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2020</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">606</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2021</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">599</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2022</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">571</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Thereafter</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">947</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,935</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">INCOME TAXES</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company’s net deferred tax assets have been fully reserved by a tax valuation allowance. The Company’s effective tax rate for the three months ended </font><font style="font-family:inherit;font-size:10pt;">September 30, 2017</font><font style="font-family:inherit;font-size:10pt;"> was </font><font style="font-family:inherit;font-size:10pt;">8.0%</font><font style="font-family:inherit;font-size:10pt;"> reflecting estimated state income taxes. The Company’s tax expense associated with taxable income during the three months ended </font><font style="font-family:inherit;font-size:10pt;">September 30, 2017</font><font style="font-family:inherit;font-size:10pt;"> was offset by the utilization of net operating loss carryforwards. </font><font style="font-family:inherit;font-size:10pt;">No</font><font style="font-family:inherit;font-size:10pt;"> income tax expense was recorded for the </font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;">September 30, 2016</font><font style="font-family:inherit;font-size:10pt;"> as it was not material due to the valuation allowance and net operating losses.</font></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">Income Taxes</font><font style="font-family:inherit;font-size:10pt;">: Deferred tax assets and liabilities are determined based on differences between financial reporting and tax bases of assets and liabilities and are measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse. A valuation allowance is established when it is more likely than not that some portion or all of the deferred tax assets will not be realized. The establishment of valuation allowances and development of projected annual effective tax rates requires significant judgment and is impacted by various estimates. Both positive and negative evidence, as well as the objectivity and verifiability of that evidence, is considered in determining the appropriateness of recording a valuation allowance on deferred tax assets. Under GAAP, the valuation allowance has been recorded to reduce the Company’s deferred tax assets to an amount that is more likely than not to be realized and is based upon the uncertainty of the realization of certain federal and state deferred tax assets related to net operating loss carryforwards and other tax attributes.</font></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">ORGANIZATION AND BACKGROUND</font></div><div style="line-height:120%;text-align:justify;padding-left:14px;text-indent:-15px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">Organization</font><font style="font-family:inherit;font-size:10pt;">: The accompanying unaudited condensed consolidated financial statements include the financial transactions and accounts of Sharps Compliance Corp. and its wholly owned subsidiaries, Sharps Compliance, Inc. of Texas (dba Sharps Compliance, Inc.), Sharps e-Tools.com Inc. (“Sharps e-Tools”), Sharps Manufacturing, Inc., Sharps Environmental Services, Inc. (dba Sharps Environmental Services of Texas, Inc.), Sharps Safety, Inc., Alpha Bio/Med Services LLC, Bio-Team Mobile LLC and Citiwaste, LLC (collectively, “Sharps” or the “Company”). All significant intercompany accounts and transactions have been eliminated upon consolidation.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">Business</font><font style="font-family:inherit;font-size:10pt;">: Sharps is a leading full-service national provider of comprehensive waste management services including medical, pharmaceutical and hazardous for small and medium quantity generators. The Company’s solutions include Sharps Recovery System™ (formerly Sharps Disposal by Mail System</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">®</sup></font><font style="font-family:inherit;font-size:10pt;">), TakeAway Medication Recovery System™, MedSafe</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">®</sup></font><font style="font-family:inherit;font-size:10pt;">, TakeAway Recycle System™,</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt"> </sup></font><font style="font-family:inherit;font-size:10pt;">ComplianceTRAC</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">SM</sup></font><font style="font-family:inherit;font-size:10pt;">, SharpsTracer</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">®</sup></font><font style="font-family:inherit;font-size:10pt;">, Sharps Secure</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">® </sup></font><font style="font-family:inherit;font-size:10pt;">Needle Disposal System, Complete Needle™ Collection & Disposal System, TakeAway Environmental Return System™, Pitch-It IV™ Poles, Asset Return System and Spill Kit and Recovery System</font><font style="font-family:inherit;font-size:10pt;font-weight:bold;">. </font><font style="font-family:inherit;font-size:10pt;">The Company also offers its route-based pick-up service in a twenty-three (</font><font style="font-family:inherit;font-size:10pt;">23</font><font style="font-family:inherit;font-size:10pt;">) state region of the South, Southeast and Northeast portions of the United States.</font></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In May 2014, guidance for revenue recognition was issued which supersedes the revenue recognition requirements currently followed by the Company. The new guidance provides for a single five-step model to be applied in determining the amount and timing of the recognition of revenue related to contracts with customers. The new standard also requires additional financial statement disclosures that will enable users to understand the nature, amount, timing and uncertainty of revenue and cash flows relating to customer contracts. In March 2016, guidance for revenue from contracts with customers regarding principal versus agent considerations was issued which modified examples to assist in the application of the guidance. Companies have an option to use either a retrospective approach or cumulative effect adjustment approach to implement the standard. The guidance is effective for annual reporting periods beginning after December 15, 2017 (effective July 1, 2018 for the Company). The Company is in the initial stages of evaluating the impact that the new accounting guidance will have on its consolidated financial statements and related disclosures as well as evaluating the available transition methods. The Company will continue to evaluate the standard as well as additional changes, modifications or interpretations which may impact the Company.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In February 2016, guidance for leases was issued, which requires balance sheet recognition for rights and obligations of all leases with terms in excess of twelve months. The new guidance also requires additional disclosures about the amount, timing and uncertainty of cash flows arising from leases. The provisions of the new guidance are effective for annual periods beginning after December 15, 2018 (effective July 1, 2019 for the Company), including interim periods within the reporting period, and early application is permitted. The Company is in the initial stages of evaluating the impact of the new guidance on its consolidated financial statements and related disclosures.</font></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">Accounts Receivable</font><font style="font-family:inherit;font-size:10pt;">: Accounts receivable consist primarily of amounts due to the Company from normal business activities. Accounts receivable balances are determined to be delinquent when the amount is past due based on the contractual terms with the customer. The Company maintains an allowance for doubtful accounts to reflect the likelihood of not collecting certain accounts receivable based on past collection history and specific risks identified among uncollected accounts. Accounts receivable are charged to the allowance for doubtful accounts when the Company determines that the receivable will not be collected and/or when the account has been referred to a third party collection agency. The Company has a history of minimal uncollectible accounts.</font></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The components of revenues by solution are as follows (in thousands):</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="15" rowspan="1"></td></tr><tr><td style="width:52%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="13" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Three-Months Ended September 30,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:2px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">% Total</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:2px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">% Total</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">REVENUES BY SOLUTION:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Mailbacks</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,339</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">55.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,249</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">65.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Route-based pickup services</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,761</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">18.2</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,465</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">15.4</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">%</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Unused medications</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,172</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">12.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">791</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">8.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Third party treatment services</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">434</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">4.5</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">68</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">0.7</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">%</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-indent:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other </font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">977</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">10.1</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">958</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">10.0</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total revenues</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9,683</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">100.0</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9,531</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">100.0</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr></table></div></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:37px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:13px;"><font style="font-family:inherit;font-size:10pt;">(1)</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company’s other products include non-mailback products such as IV poles, accessories, containers, asset return boxes and other miscellaneous items.</font></div></td></tr></table></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">Revenue Recognition:</font><font style="font-family:inherit;font-size:10pt;"> The Company recognizes revenue when services are provided and from product sales when (i) goods are shipped or delivered, and title and risk of loss pass to the customer, (ii) the price is substantially fixed or determinable and (iii) collectability is reasonably assured except for those sales via multiple-deliverable revenue arrangements. Provisions for certain rebates, product returns and discounts to customers are accounted for as reductions in sales in the same period the related sales are recorded. Product discounts granted are based on the terms of arrangements with direct, indirect and other market participants, as well as market conditions, including prices charged by competitors. Rebates are estimated based on contractual terms, historical experience, trend analysis and projected market conditions in the various markets served. Service agreements which include a vendor managed inventory program include terms that meet the “bill and hold” criteria and as such are recognized when the order is completed, at which point title has transferred, there are no acceptance provisions and amounts are segregated in the Company’s warehouse. During both the </font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;">September 30, 2017</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2016</font><font style="font-family:inherit;font-size:10pt;">, the Company recorded revenue from inventory builds that are held in vendor managed inventory under these service agreements of </font><font style="font-family:inherit;font-size:10pt;">$1.0 million</font><font style="font-family:inherit;font-size:10pt;">. As of </font><font style="font-family:inherit;font-size:10pt;">September 30, 2017</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">June 30, 2017</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">$2.9 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$2.7 million</font><font style="font-family:inherit;font-size:10pt;">, respectively, of solutions sold through that date were held in vendor managed inventory pending fulfillment or shipment to patients of pharmaceutical manufacturers who offer these solutions to patients in an ongoing patient support program.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Certain products offered by the Company have revenue producing components that are recognized over multiple delivery points (Sharps Recovery System and various other solutions like the TakeAway Medication Recovery Systems referred to as “Mailbacks” and Sharps Pump and Asset Return Systems, referred to as “Pump Returns”) and can consist of up to three separate elements, or units of measure, as follows: (1) the sale of the compliance and container system, (2) return transportation and (3) treatment service. In accordance with the relative selling price methodology, an estimated selling price is determined for all deliverables that qualify for separate units of accounting. The actual consideration received in a multiple-deliverable arrangement is then allocated to the units based on their relative sales price. The selling price for the transportation revenue and the treatment revenue utilizes third party evidence. The Company estimates the selling price of the compliance and container system based on the product and services, provided, including compliance with local, state and federal laws, adherence to stringent manufacturing and testing requirements, safety to the patient and the community as well as storage and containment capabilities.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Revenue for the sale of the compliance and container is recognized upon delivery to the customer, at which time the customer takes title and assumes risk of ownership. Transportation revenue is recognized when the customer returns the compliance and container system and the container has been received at the Company’s owned or contracted facilities. The compliance and container system is mailed or delivered by an alternative logistics provider to the Company’s owned or contracted facilities. Treatment revenue is recognized upon the destruction or conversion and proof of receipt and treatment having been performed on the container. Since the transportation element and the treatment elements are undelivered services at the point of initial sale of the compliance and container, transportation and treatment revenue is deferred until the services are performed. The current and long-term portions of deferred revenues are determined through regression analysis and historical trends. Furthermore, through regression analysis of historical data, the Company has determined that a certain percentage of all compliance and container systems sold may not be returned. Accordingly, a portion of the transportation and treatment elements are recognized at the point of sale.</font></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">At </font><font style="font-family:inherit;font-size:10pt;">September 30, 2017</font><font style="font-family:inherit;font-size:10pt;">, long-term debt consisted of the following (in thousands):</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4" rowspan="1"></td></tr><tr><td style="width:89%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Non-interest bearing, unsecured note payable assumed in acquisition, monthly payments of $7; maturing September 2018.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">83</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Term loan, bearing interest at 3.75%, monthly payments of $43; maturing March 2022.</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,370</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total long-term debt</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,453</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Less: current portion</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">600</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Long-term debt, net of current portion</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,853</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following information is necessary to calculate earnings per share for the periods presented (in thousands, except per-share data):</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="9" rowspan="1"></td></tr><tr><td style="width:76%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Three-Months Ended<br clear="none"/>September 30,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:2px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:2px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2016</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net income (loss), as reported</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">75</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(967</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Weighted average common shares outstanding</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16,008</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15,868</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Effect of dilutive stock options</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">85</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Weighted average diluted common shares outstanding</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16,093</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15,868</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net income (loss) per common share</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Basic and diluted</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.00</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.06</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Employee stock options excluded from computation of dilutive income per share amounts because their effect would be anti-dilutive</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">231</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">145</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">At </font><font style="font-family:inherit;font-size:10pt;">September 30, 2017</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">June 30, 2017</font><font style="font-family:inherit;font-size:10pt;">, intangible assets consisted of the following (in thousands):</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="27" rowspan="1"></td></tr><tr><td style="width:21%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:7%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:6%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:7%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:6%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">September 30, 2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">June 30, 2017</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Estimated<br clear="none"/>Useful Lives</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Original</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Amount</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Accumulated</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Amortization</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Net</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Amount</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Original</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Amount</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Accumulated</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Amortization</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Net</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Amount</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Customer relationships</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7 years</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,007</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(597</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,410</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,007</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(490</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,517</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Permits</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6 - 15 years</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,414</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(314</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,100</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,373</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(288</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,085</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Patents</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5 - 17 years</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">383</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(268</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">115</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">383</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(264</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">119</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Tradename</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7 years</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">270</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(48</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">222</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">270</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(39</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">231</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Non-compete</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5 years</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">117</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(29</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">88</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">117</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(23</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">94</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total intangible assets, net</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,191</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,256</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,935</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,150</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,104</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,046</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The components of inventory are as follows (in thousands):</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:71%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">September 30, 2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">June 30, 2017</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Raw materials</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,255</font></div></td><td style="vertical-align:bottom;border-top:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,272</font></div></td><td style="vertical-align:bottom;border-top:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Finished goods</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,984</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,826</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,239</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,098</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">REVENUES BY SOLUTION</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The components of revenues by solution are as follows (in thousands):</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="15" rowspan="1"></td></tr><tr><td style="width:52%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="13" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Three-Months Ended September 30,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:2px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">% Total</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:2px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">% Total</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">REVENUES BY SOLUTION:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Mailbacks</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,339</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">55.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,249</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">65.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Route-based pickup services</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,761</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">18.2</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,465</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">15.4</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">%</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Unused medications</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,172</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">12.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">791</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">8.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Third party treatment services</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">434</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">4.5</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">68</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">0.7</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">%</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-indent:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other </font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">977</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">10.1</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">958</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">10.0</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total revenues</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9,683</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">100.0</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9,531</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">100.0</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr></table></div></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:37px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:13px;"><font style="font-family:inherit;font-size:10pt;">(1)</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company’s other products include non-mailback products such as IV poles, accessories, containers, asset return boxes and other miscellaneous items.</font></div></td></tr></table></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">Stock-Based Compensation</font><font style="font-family:inherit;font-size:10pt;">: Stock-based compensation cost for options and restricted stock awarded to employees and directors is measured at the grant date, based on the calculated fair value of the award and is recognized as an expense over the requisite service period (generally the vesting period of the equity grant).</font></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">SIGNIFICANT ACCOUNTING POLICIES</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">Revenue Recognition:</font><font style="font-family:inherit;font-size:10pt;"> The Company recognizes revenue when services are provided and from product sales when (i) goods are shipped or delivered, and title and risk of loss pass to the customer, (ii) the price is substantially fixed or determinable and (iii) collectability is reasonably assured except for those sales via multiple-deliverable revenue arrangements. Provisions for certain rebates, product returns and discounts to customers are accounted for as reductions in sales in the same period the related sales are recorded. Product discounts granted are based on the terms of arrangements with direct, indirect and other market participants, as well as market conditions, including prices charged by competitors. Rebates are estimated based on contractual terms, historical experience, trend analysis and projected market conditions in the various markets served. Service agreements which include a vendor managed inventory program include terms that meet the “bill and hold” criteria and as such are recognized when the order is completed, at which point title has transferred, there are no acceptance provisions and amounts are segregated in the Company’s warehouse. During both the </font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;">September 30, 2017</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2016</font><font style="font-family:inherit;font-size:10pt;">, the Company recorded revenue from inventory builds that are held in vendor managed inventory under these service agreements of </font><font style="font-family:inherit;font-size:10pt;">$1.0 million</font><font style="font-family:inherit;font-size:10pt;">. As of </font><font style="font-family:inherit;font-size:10pt;">September 30, 2017</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">June 30, 2017</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">$2.9 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$2.7 million</font><font style="font-family:inherit;font-size:10pt;">, respectively, of solutions sold through that date were held in vendor managed inventory pending fulfillment or shipment to patients of pharmaceutical manufacturers who offer these solutions to patients in an ongoing patient support program.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Certain products offered by the Company have revenue producing components that are recognized over multiple delivery points (Sharps Recovery System and various other solutions like the TakeAway Medication Recovery Systems referred to as “Mailbacks” and Sharps Pump and Asset Return Systems, referred to as “Pump Returns”) and can consist of up to three separate elements, or units of measure, as follows: (1) the sale of the compliance and container system, (2) return transportation and (3) treatment service. In accordance with the relative selling price methodology, an estimated selling price is determined for all deliverables that qualify for separate units of accounting. The actual consideration received in a multiple-deliverable arrangement is then allocated to the units based on their relative sales price. The selling price for the transportation revenue and the treatment revenue utilizes third party evidence. The Company estimates the selling price of the compliance and container system based on the product and services, provided, including compliance with local, state and federal laws, adherence to stringent manufacturing and testing requirements, safety to the patient and the community as well as storage and containment capabilities.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Revenue for the sale of the compliance and container is recognized upon delivery to the customer, at which time the customer takes title and assumes risk of ownership. Transportation revenue is recognized when the customer returns the compliance and container system and the container has been received at the Company’s owned or contracted facilities. The compliance and container system is mailed or delivered by an alternative logistics provider to the Company’s owned or contracted facilities. Treatment revenue is recognized upon the destruction or conversion and proof of receipt and treatment having been performed on the container. Since the transportation element and the treatment elements are undelivered services at the point of initial sale of the compliance and container, transportation and treatment revenue is deferred until the services are performed. The current and long-term portions of deferred revenues are determined through regression analysis and historical trends. Furthermore, through regression analysis of historical data, the Company has determined that a certain percentage of all compliance and container systems sold may not be returned. Accordingly, a portion of the transportation and treatment elements are recognized at the point of sale.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">Income Taxes</font><font style="font-family:inherit;font-size:10pt;">: Deferred tax assets and liabilities are determined based on differences between financial reporting and tax bases of assets and liabilities and are measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse. A valuation allowance is established when it is more likely than not that some portion or all of the deferred tax assets will not be realized. The establishment of valuation allowances and development of projected annual effective tax rates requires significant judgment and is impacted by various estimates. Both positive and negative evidence, as well as the objectivity and verifiability of that evidence, is considered in determining the appropriateness of recording a valuation allowance on deferred tax assets. Under GAAP, the valuation allowance has been recorded to reduce the Company’s deferred tax assets to an amount that is more likely than not to be realized and is based upon the uncertainty of the realization of certain federal and state deferred tax assets related to net operating loss carryforwards and other tax attributes.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">Goodwill and Other Identifiable Intangible Assets:</font><font style="font-family:inherit;font-size:10pt;"> Finite-lived intangible assets are amortized over their respective estimated useful lives and evaluated for impairment periodically whenever events or changes in circumstances indicate that their related carrying values may not be fully recoverable. Goodwill is assessed for impairment at least annually. The Company generally performs its annual goodwill impairment analysis using a quantitative approach. The quantitative goodwill impairment test identifies the existence of potential impairment by comparing the fair value of our single reporting unit with its carrying value, including goodwill. If the fair value of a reporting unit exceeds its carrying value, the reporting unit's goodwill is considered not to be impaired. If the carrying value of a reporting unit exceeds its fair value, an impairment charge is recognized in an amount equal to that excess. The impairment charge recognized is limited to the amount of goodwill present in our single reporting unit. These estimates and assumptions could have a significant impact on whether or not an impairment charge is recognized and the amount of any such charge. The Company performs its annual impairment assessment of goodwill during the fourth quarter of each fiscal year. The Company determined that there was no impairment during the prior year ended </font><font style="font-family:inherit;font-size:10pt;">June 30, 2017</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">Accounts Receivable</font><font style="font-family:inherit;font-size:10pt;">: Accounts receivable consist primarily of amounts due to the Company from normal business activities. Accounts receivable balances are determined to be delinquent when the amount is past due based on the contractual terms with the customer. The Company maintains an allowance for doubtful accounts to reflect the likelihood of not collecting certain accounts receivable based on past collection history and specific risks identified among uncollected accounts. Accounts receivable are charged to the allowance for doubtful accounts when the Company determines that the receivable will not be collected and/or when the account has been referred to a third party collection agency. The Company has a history of minimal uncollectible accounts. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">Stock-Based Compensation</font><font style="font-family:inherit;font-size:10pt;">: Stock-based compensation cost for options and restricted stock awarded to employees and directors is measured at the grant date, based on the calculated fair value of the award and is recognized as an expense over the requisite service period (generally the vesting period of the equity grant).</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">Fair Value of Financial Instruments</font><font style="font-family:inherit;font-size:10pt;">: The Company considers the fair value of all financial instruments, including cash and cash equivalents, accounts receivable and accounts payable to approximate their carrying values at </font><font style="font-family:inherit;font-size:10pt;">September 30, 2017</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">June 30, 2017</font><font style="font-family:inherit;font-size:10pt;"> due to their short-term nature. The carrying value of the Company’s debt approximates fair value due to the market rates of interest.</font></div></div>

EX-101.SCH 7 smed-20170930.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 2102100 - Disclosure - BASIS OF PRESENTATION link:presentationLink link:calculationLink link:definitionLink 1001000 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) link:presentationLink link:calculationLink link:definitionLink 1001501 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 1004000 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) link:presentationLink link:calculationLink link:definitionLink 1002000 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) link:presentationLink link:calculationLink link:definitionLink 1003000 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Unaudited) link:presentationLink link:calculationLink link:definitionLink 0001000 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink 2108100 - Disclosure - EARNINGS PER SHARE link:presentationLink link:calculationLink link:definitionLink 2408402 - Disclosure - EARNINGS PER SHARE (Details) link:presentationLink link:calculationLink link:definitionLink 2308301 - Disclosure - EARNINGS PER SHARE (Tables) link:presentationLink link:calculationLink link:definitionLink 2109100 - Disclosure - EQUITY TRANSACTIONS link:presentationLink link:calculationLink link:definitionLink 2409402 - Disclosure - EQUITY TRANSACTIONS (Details) link:presentationLink link:calculationLink link:definitionLink 2309301 - Disclosure - EQUITY TRANSACTIONS (Tables) link:presentationLink link:calculationLink link:definitionLink 2110100 - Disclosure - GOODWILL AND INTANGIBLE ASSETS link:presentationLink link:calculationLink link:definitionLink 2410402 - Disclosure - GOODWILL AND INTANGIBLE ASSETS (Details) link:presentationLink link:calculationLink link:definitionLink 2410402 - Disclosure - GOODWILL AND INTANGIBLE ASSETS (Details) link:presentationLink link:calculationLink link:definitionLink 2310301 - Disclosure - GOODWILL AND INTANGIBLE ASSETS (Tables) link:presentationLink link:calculationLink link:definitionLink 2105100 - Disclosure - INCOME TAXES link:presentationLink link:calculationLink link:definitionLink 2405401 - Disclosure - INCOME TAXES (Details) link:presentationLink link:calculationLink link:definitionLink 2111100 - Disclosure - INVENTORY link:presentationLink link:calculationLink link:definitionLink 2411402 - Disclosure - INVENTORY (Details) link:presentationLink link:calculationLink link:definitionLink 2311301 - Disclosure - INVENTORY (Tables) link:presentationLink link:calculationLink link:definitionLink 2106100 - Disclosure - NOTES PAYABLE AND LONG-TERM DEBT link:presentationLink link:calculationLink link:definitionLink 2406402 - Disclosure - NOTES PAYABLE AND LONG-TERM DEBT - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2406403 - Disclosure - NOTES PAYABLE AND LONG-TERM DEBT - Schedule of debt instruments (Details) link:presentationLink link:calculationLink link:definitionLink 2406404 - Disclosure - NOTES PAYABLE AND LONG-TERM DEBT - Schedule of payments due on long-term debt (Details) link:presentationLink link:calculationLink link:definitionLink 2306301 - Disclosure - NOTES PAYABLE AND LONG-TERM DEBT (Tables) link:presentationLink link:calculationLink link:definitionLink 2101100 - Disclosure - ORGANIZATION AND BACKGROUND link:presentationLink link:calculationLink link:definitionLink 2401401 - Disclosure - ORGANIZATION AND BACKGROUND (Details) link:presentationLink link:calculationLink link:definitionLink 2104100 - Disclosure - RECENTLY ISSUED ACCOUNTING STANDARDS link:presentationLink link:calculationLink link:definitionLink 2112100 - Disclosure - REVENUES BY SOLUTION link:presentationLink link:calculationLink link:definitionLink 2412402 - Disclosure - REVENUES BY SOLUTION (Details) link:presentationLink link:calculationLink link:definitionLink 2312301 - Disclosure - REVENUES BY SOLUTION (Tables) link:presentationLink link:calculationLink link:definitionLink 2103100 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES link:presentationLink link:calculationLink link:definitionLink 2403402 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Details) link:presentationLink link:calculationLink link:definitionLink 2203201 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Policies) link:presentationLink link:calculationLink link:definitionLink 2107100 - Disclosure - STOCK-BASED COMPENSATION link:presentationLink link:calculationLink link:definitionLink 2407402 - Disclosure - STOCK-BASED COMPENSATION (Details) link:presentationLink link:calculationLink link:definitionLink 2307301 - Disclosure - STOCK-BASED COMPENSATION (Tables) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 8 smed-20170930_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT EX-101.DEF 9 smed-20170930_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 10 smed-20170930_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Statement of Cash Flows [Abstract] CASH FLOWS FROM OPERATING ACTIVITIES Net Cash Provided by (Used in) Operating Activities, Continuing Operations [Abstract] Net income Net Income (Loss) Attributable to Parent Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities: Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Depreciation and amortization Depreciation, Depletion and Amortization (Gain) loss on disposal of property, plant and equipment Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property Stock-based compensation expense Share-based Compensation Changes in operating assets and liabilities, net of effects of business acquisitions: Increase (Decrease) in Operating Capital [Abstract] Accounts receivable Increase (Decrease) in Accounts Receivable Inventory Increase (Decrease) in Inventories Prepaid and other assets Increase (Decrease) in Prepaid Expense and Other Assets Accounts payable and accrued liabilities Increase (Decrease) in Accounts Payable and Accrued Liabilities Deferred revenue Increase (Decrease) in Deferred Revenue NET CASH PROVIDED BY (USED IN) OPERATING ACTIVITIES Net Cash Provided by (Used in) Operating Activities CASH FLOWS FROM INVESTING ACTIVITIES Net Cash Provided by (Used in) Investing Activities, Continuing Operations [Abstract] Purchase of property, plant and equipment Payments to Acquire Property, Plant, and Equipment Cash proceeds from sale of property, plant and equipment Proceeds from Sale of Property, Plant, and Equipment Additions to intangible assets Payments to Acquire Intangible Assets Payments for business acquisitions, net of cash acquired Payments to Acquire Businesses, Net of Cash Acquired NET CASH USED IN INVESTING ACTIVITIES Net Cash Provided by (Used in) Investing Activities CASH FLOWS FROM FINANCING ACTIVITIES Net Cash Provided by (Used in) Financing Activities, Continuing Operations [Abstract] Proceeds from exercise of stock options Proceeds from Issuance of Common Stock Proceeds from long-term debt Proceeds from Issuance of Long-term Debt Repayments of long-term debt Repayments of Long-term Debt NET CASH PROVIDED BY (USED IN) FINANCING ACTIVITIES Net Cash Provided by (Used in) Financing Activities NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS Cash and Cash Equivalents, Period Increase (Decrease) CASH AND CASH EQUIVALENTS, beginning of period Cash and Cash Equivalents, at Carrying Value CASH AND CASH EQUIVALENTS, end of period SUPPLEMENTAL CASH FLOW DISCLOSURES: Supplemental Cash Flow Elements [Abstract] Income taxes paid Income Taxes Paid, Net Interest paid on long-term debt Interest Expense, Long-term Debt NON-CASH INVESTING AND FINANCING ACTIVITIES: Noncash Investing and Financing Items [Abstract] Issuance of common stock for acquisition Noncash Or Part Noncash Acquisition Of Assets By Issuing Equity Securities The amount of assets that an Entity acquires by issuing equity securities in a noncash (or part noncash) acquisition. Noncash is defined as information about all investing and financing activities of an enterprise during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period. Unpaid consideration related to acquisitions Unpaid consideration related to acquisition Business acquisition amount of escrow deposit and other unpaid consideration. Transfer of equipment to inventory Transfer of equipment to inventory This element represents the noncash transfer of equipment from fixed assets into inventory. Property, plant and equipment financed through accounts payable Noncash or Part Noncash Related Purchases of Property Plant And Equipment The amount of noncash or part noncash for purchases of and capital improvements on property, plant and equipment. Noncash is defined as information about all investing and financing activities of an enterprise during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period. Disclosure of Compensation Related Costs, Share-based Payments [Abstract] STOCK-BASED COMPENSATION Disclosure of Compensation Related Costs, Share-based Payments [Text Block] Earnings Per Share [Abstract] Schedule of Earnings Per Share Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] EARNINGS PER SHARE Earnings Per Share [Text Block] Statement of Financial Position [Abstract] Accounts receivable, allowance for doubtful accounts Allowance for Doubtful Accounts Receivable, Current Common stock, par value (in dollars per share) Common Stock, Par or Stated Value Per Share Common stock, shares authorized (in shares) Common Stock, Shares Authorized Common stock, shares issued (in shares) Common Stock, Shares, Issued Common stock, shares outstanding (in shares) Common Stock, Shares, Outstanding Treasury stock, shares repurchased (in shares) Treasury Stock, Shares Statement of Stockholders' Equity [Abstract] Statement [Table] Statement [Table] Equity Components [Axis] Equity Components [Axis] Equity Component [Domain] Equity Component [Domain] Common Stock Common Stock [Member] Treasury Stock Treasury Stock [Member] Additional Paid-in Capital Additional Paid-in Capital [Member] Accumulated Deficit Retained Earnings [Member] Statement [Line Items] Statement [Line Items] Balance at beginning (in shares) Shares, Issued Balances at beginning Stockholders' Equity Attributable to Parent Exercise of stock options (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period Exercise of stock options Stock Issued During Period, Value, Stock Options Exercised Stock-based compensation Adjustments to Additional Paid in Capital, Share-based Compensation, Requisite Service Period Recognition Issuance of common stock for acquisition (in shares) Stock Issued During Period, Shares, Acquisitions Issuance of common shares for acquisition Stock Issued During Period, Value, Acquisitions Issuance of restricted stock (in shares) Stock Issued During Period, Shares, Restricted Stock Award, Gross Balance at end (in shares) Balances at end Debt Disclosure [Abstract] NOTES PAYABLE AND LONG-TERM DEBT Debt Disclosure [Text Block] Inventory Disclosure [Abstract] Schedule of Inventory Schedule of Inventory, Current [Table Text Block] Income Tax Disclosure [Abstract] INCOME TAXES Income Tax Disclosure [Text Block] Stockholders' Equity Note [Abstract] Stock options exercised [Abstract] Stock options exercised [Abstract] Options exercised (in shares) Proceeds from stock options exercised Proceeds from Stock Options Exercised Average exercise price per share (in dollars per share) Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price Compensation expense related to non-vested awards Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized Weighted average period Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition Line of Credit Facility [Table] Line of Credit Facility [Table] Debt Instrument [Axis] Debt Instrument [Axis] Debt Instrument, Name [Domain] Debt Instrument, Name [Domain] Credit Agreement Credit Agreement [Member] A contractual arrangement with a lender under which borrowings can be made up to a specific amount at any point in time, and under which borrowings outstanding may be either short-term or long-term, depending upon the particulars. Variable Rate [Axis] Variable Rate [Axis] Variable Rate [Domain] Variable Rate [Domain] LIBOR London Interbank Offered Rate (LIBOR) [Member] Credit Facility [Axis] Credit Facility [Axis] Credit Facility [Domain] Credit Facility [Domain] Working Capital Working Capital [Member] Working capital is money available to a company for day-to-day operations. Letter of Credit Letter of Credit [Member] Acquisitions Series of Individually Immaterial Business Acquisitions [Member] Long-term Debt, Type [Axis] Long-term Debt, Type [Axis] Long-term Debt, Type [Domain] Long-term Debt, Type [Domain] Unsecured Note Payable Unsecured Debt [Member] Term Loan Term Loan [Member] A term loan is a monetary loan that is repaid in regular payments over a set period of time. Term loans usually last between one and ten years. Range [Axis] Range [Axis] Range [Domain] Range [Domain] Minimum Minimum [Member] Maximum Maximum [Member] Guarantor Obligations, Nature [Axis] Guarantor Obligations, Nature [Axis] Guarantor Obligations, Nature [Domain] Guarantor Obligations, Nature [Domain] Performance bonds Surety Bond [Member] Line of Credit Facility [Line Items] Line of Credit Facility [Line Items] Maximum borrowing capacity Line of Credit Facility, Maximum Borrowing Capacity Percentage of eligible accounts receivable considered for borrowing base Percentage of eligible accounts receivable considered for borrowing base Percentage of eligible accounts receivable considered for borrowing base as defined in the credit agreement. Percentage of eligible inventory considered for borrowing base Percentage of eligible inventory considered for borrowing base Percentage of eligible inventory considered for borrowing base as defined in the credit agreement. Borrowing base, monetary benchmark Borrowing Base, Monetary Benchmark For Percentage Of Eligible Accounts Borrowing Base, Monetary Benchmark For Percentage Of Eligible Accounts Percentage of portion allocated to acquisition purchase price Percentage of Portion Allocated to Acquisition Purchase Price Maximum borrowing limit percentage under line of credit facility as per the terms of the credit agreement. Maturity period Debt Instrument, Term Basis spread of variable rate Debt Instrument, Basis Spread on Variable Rate Debt instrument, term of variable rate Debt Instrument, Term of Variable Rate Term of interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index. Interest rate Line of Credit Facility, Interest Rate at Period End Unused capacity, commitment fee percentage Line of Credit Facility, Unused Capacity, Commitment Fee Percentage Remaining borrowing capacity Line of Credit Facility, Remaining Borrowing Capacity Debt cash flow leverage ratio Debt Cash Flow Leverage Ratio Ratio used to determine cash flows leverage tiers of the company. Debt service coverage ratio Debt Service Coverage Ratio Ratio used by bank loan officers in determining income property loans. Debt cash flow of leverage ratio as on December 31, 2017 Debt Cash Flow Leverage Ratio Period 1 Ratio used to determine cash flows leverage tiers of the company as on December 31, 2017. Decrease in cash flow of leverage ratio as on March 31, 2018 Debt Cash Flow Leverage Ratio Period 2 Ratio used to determine cash flows leverage tiers of the company as on period 2. Amount outstanding Long-term Line of Credit Performance bonds outstanding, financial assurance Guarantor Obligations, Maximum Exposure, Undiscounted Components of inventory [Abstract] Inventory, Net, Items Net of Reserve Alternative [Abstract] Raw materials Inventory, Raw Materials, Net of Reserves Finished goods Inventory, Finished Goods, Net of Reserves Total Inventory, Net Long-term Debt, Fiscal Year Maturity [Abstract] Long-term Debt, Fiscal Year Maturity [Abstract] 2018 Long-term Debt, Maturities, Repayments of Principal, Remainder of Fiscal Year 2019 Long-term Debt, Maturities, Repayments of Principal in Year Two 2020 Long-term Debt, Maturities, Repayments of Principal in Year Three 2021 Long-term Debt, Maturities, Repayments of Principal in Year Four 2022 Long-term Debt, Maturities, Repayments of Principal in Year Five Total long-term debt Long-term Debt Goodwill and Intangible Assets Disclosure [Abstract] GOODWILL AND INTANGIBLE ASSETS Goodwill and Intangible Assets Disclosure [Text Block] Accounting Policies [Abstract] SIGNIFICANT ACCOUNTING POLICIES Significant Accounting Policies [Text Block] Income tax expense Income Tax Expense (Benefit) Effective income tax rate Effective Income Tax Rate Reconciliation, Percent Schedule of intangible assets Schedule of Finite-Lived Intangible Assets [Table Text Block] Schedule of future amortization of intangible assets Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block] Schedule of Long-term Debt Instruments [Table] Schedule of Long-term Debt Instruments [Table] Debt Instrument [Line Items] Debt Instrument [Line Items] Long-term Debt, Unclassified [Abstract] Long-term Debt, Unclassified [Abstract] Monthly payments Debt Instrument, Periodic Payment Less: current portion Long-term Debt, Current Maturities Long-term debt, net of current portion Long-term Debt, Excluding Current Maturities Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table Text Block] Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table Text Block] Stock options exercised to purchase common stock Stock options exercised to purchase common stock [Table Text Block] Tabular disclosure of stock options exercised to purchase common shares. Segment Reporting [Abstract] Schedule of Segment Reporting Information, by Segment [Table] Schedule of Segment Reporting Information, by Segment [Table] Segments [Axis] Segments [Axis] Segments [Domain] Segments [Domain] Mailbacks Mailbacks [Member] Refers to revenue from mailbacks. Route-based pickup services Route-based Pickup Services [Member] Refers to revenue from route-based pickup services. Unused medications Unused Medications [Member] Refers to revenue from unused medications. Third party treatment services Third Party Treatment Services [Member] Refers to revenue from third party treatment services. Other Other Segments [Member] Segment Reporting Information [Line Items] Segment Reporting Information [Line Items] Revenue reported Revenue, Net Revenue percentage Concentration Risk, Percentage Schedule of billings by solution Reconciliation of Other Significant Reconciling Items from Segments to Consolidated [Table Text Block] Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table] Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table] Income Statement Location [Axis] Income Statement Location [Axis] Income Statement Location [Domain] Income Statement Location [Domain] Cost of revenues Cost of Sales [Member] Selling, general and administrative Selling, General and Administrative Expenses [Member] Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items] Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items] REVENUES BY SOLUTION Segment Reporting Disclosure [Text Block] Net income (loss), as reported Weighted average common shares outstanding (in shares) Weighted Average Number of Shares Outstanding, Basic Effect of dilutive stock options (in shares) Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants Weighted average diluted common shares outstanding (in shares) Weighted Average Number of Shares Outstanding, Diluted Net income (loss) per common share Earnings Per Share, Basic and Diluted [Abstract] Basic and diluted (in dollars per share) Earnings Per Share, Basic and Diluted Employee stock options excluded from computation of dilutive income per share amounts because their effect would be anti-dilutive (in shares) Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount New Accounting Pronouncements and Changes in Accounting Principles [Abstract] RECENTLY ISSUED ACCOUNTING STANDARDS Description of New Accounting Pronouncements Not yet Adopted [Text Block] ASSETS Assets [Abstract] CURRENT ASSETS Assets, Current [Abstract] Cash and cash equivalents Accounts receivable, net of allowance for doubtful accounts of $80 and $78, respectively Accounts Receivable, Net, Current Inventory, net Prepaid and other current assets Prepaid Expense and Other Assets, Current TOTAL CURRENT ASSETS Assets, Current PROPERTY, PLANT AND EQUIPMENT, net Property, Plant and Equipment, Net OTHER ASSETS Other Assets, Noncurrent GOODWILL Goodwill INTANGIBLE ASSETS, net Finite-Lived Intangible Assets, Net TOTAL ASSETS Assets LIABILITIES AND STOCKHOLDERS' EQUITY Liabilities and Equity [Abstract] CURRENT LIABILITIES Liabilities, Current [Abstract] EX-101.PRE 11 smed-20170930_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT XML 12 R1.htm IDEA: XBRL DOCUMENT

Document and Entity Information - shares	3 Months Ended
Document and Entity Information - shares	Sep. 30, 2017	Oct. 30, 2017
Document and Entity Information [Abstract]
Entity Registrant Name	SHARPS COMPLIANCE CORP
Entity Central Index Key	0000898770
Current Fiscal Year End Date	--06-30
Entity Filer Category	Smaller Reporting Company
Entity Common Stock, Shares Outstanding		16,008,412
Document Fiscal Year Focus	2018
Document Fiscal Period Focus	Q1
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Sep. 30, 2017

XML 13 R2.htm IDEA: XBRL DOCUMENT

CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) - USD ($) $ in Thousands	Sep. 30, 2017	Jun. 30, 2017
CURRENT ASSETS
Cash and cash equivalents	$ 5,160	$ 4,675
Accounts receivable, net of allowance for doubtful accounts of $80 and $78, respectively	7,279	7,553
Inventory, net	4,239	4,098
Prepaid and other current assets	566	694
TOTAL CURRENT ASSETS	17,244	17,020
PROPERTY, PLANT AND EQUIPMENT, net	6,491	6,543
OTHER ASSETS	122	120
GOODWILL	6,735	6,735
INTANGIBLE ASSETS, net	3,935	4,046
TOTAL ASSETS	34,527	34,464
CURRENT LIABILITIES
Accounts payable	1,978	1,710
Accrued liabilities	1,518	1,800
Current maturities of long-term debt	600	601
Deferred revenue	2,396	2,421
TOTAL CURRENT LIABILITIES	6,492	6,532
LONG-TERM DEFERRED REVENUE, net of current portion	528	478
OTHER LONG-TERM LIABILITIES	171	165
LONG-TERM DEBT, net of currrent portion	1,853	2,002
TOTAL LIABILITIES	9,044	9,177
COMMITMENTS AND CONTINGENCIES
STOCKHOLDERS' EQUITY
Common stock, $0.01 par value per share; 20,000,000 shares authorized; 16,304,027 shares issued and 16,008,412 shares outstanding	163	163
Treasury stock, at cost, 295,615 shares repurchased	(1,554)	(1,554)
Additional paid-in capital	28,184	28,063
Accumulated deficit	(1,310)	(1,385)
TOTAL STOCKHOLDERS' EQUITY	25,483	25,287
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY	$ 34,527	$ 34,464

XML 14 R3.htm IDEA: XBRL DOCUMENT

CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical) - USD ($) $ in Thousands	Sep. 30, 2017	Jun. 30, 2017
Statement of Financial Position [Abstract]
Accounts receivable, allowance for doubtful accounts	$ 80	$ 78
Common stock, par value (in dollars per share)	$ 0.01	$ 0.01
Common stock, shares authorized (in shares)	20,000,000	20,000,000
Common stock, shares issued (in shares)	16,304,027	16,304,027
Common stock, shares outstanding (in shares)	16,008,412	16,008,412
Treasury stock, shares repurchased (in shares)	295,615	295,615

XML 15 R4.htm IDEA: XBRL DOCUMENT

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) - USD ($) shares in Thousands	3 Months Ended
	Sep. 30, 2017	Sep. 30, 2016
Income Statement [Abstract]
REVENUES	$ 9,683,000	$ 9,531,000
Cost of revenues	6,655,000	6,572,000
GROSS PROFIT	3,028,000	2,959,000
Selling, general and administrative	2,725,000	3,699,000
Depreciation and amortization	202,000	200,000
OPERATING INCOME (LOSS)	101,000	(940,000)
OTHER INCOME (EXPENSE)
Interest income	5,000	4,000
Interest expense	(24,000)	(31,000)
TOTAL OTHER EXPENSE	(19,000)	(27,000)
INCOME (LOSS) BEFORE INCOME TAXES	82,000	(967,000)
INCOME TAX EXPENSE	(7,000)	0
NET INCOME (LOSS)	$ 75,000	$ (967,000)
NET INCOME (LOSS) PER COMMON SHARE - Basic and Diluted
Basic and Diluted (in dollars per share)	$ 0.00	$ (0.06)
WEIGHTED AVERAGE SHARES USED IN COMPUTING INCOME (LOSS) PER COMMON SHARE:
Basic (in shares)	16,008	15,868
Diluted (in shares)	16,093	15,868

XML 16 R5.htm IDEA: XBRL DOCUMENT

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Unaudited) - USD ($) $ in Thousands	Total	Common Stock	Treasury Stock	Additional Paid-in Capital	Accumulated Deficit
Balance at beginning (in shares) at Jun. 30, 2016		15,740,458	295,615
Balances at beginning at Jun. 30, 2016	$ 23,843	$ 158	$ (1,554)	$ 25,331	$ (92)
Exercise of stock options (in shares)		95,050
Exercise of stock options	342	$ 1		341
Stock-based compensation	496			496
Issuance of common stock for acquisition (in shares)		415,527
Issuance of common shares for acquisition	1,899	$ 4		1,895
Issuance of restricted stock (in shares)		52,992
Net income	(1,293)				(1,293)
Balance at end (in shares) at Jun. 30, 2017		16,304,027	295,615
Balances at end at Jun. 30, 2017	$ 25,287	$ 163	$ (1,554)	28,063	(1,385)
Exercise of stock options (in shares)	0
Stock-based compensation	$ 121			121
Net income	75				75
Balance at end (in shares) at Sep. 30, 2017		16,304,027	295,615
Balances at end at Sep. 30, 2017	$ 25,483	$ 163	$ (1,554)	$ 28,184	$ (1,310)

XML 17 R6.htm IDEA: XBRL DOCUMENT

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Sep. 30, 2017	Sep. 30, 2016
CASH FLOWS FROM OPERATING ACTIVITIES
Net income	$ 75	$ (967)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Depreciation and amortization	390	338
(Gain) loss on disposal of property, plant and equipment	(2)	6
Stock-based compensation expense	121	139
Changes in operating assets and liabilities, net of effects of business acquisitions:
Accounts receivable	274	(772)
Inventory	(72)	(252)
Prepaid and other assets	126	(213)
Accounts payable and accrued liabilities	(29)	644
Deferred revenue	25	285
NET CASH PROVIDED BY (USED IN) OPERATING ACTIVITIES	908	(792)
CASH FLOWS FROM INVESTING ACTIVITIES
Purchase of property, plant and equipment	(235)	(806)
Cash proceeds from sale of property, plant and equipment	3	13
Additions to intangible assets	(41)	0
Payments for business acquisitions, net of cash acquired	0	(7,062)
NET CASH USED IN INVESTING ACTIVITIES	(273)	(7,855)
CASH FLOWS FROM FINANCING ACTIVITIES
Proceeds from exercise of stock options	0	141
Proceeds from long-term debt	0	3,000
Repayments of long-term debt	(150)	(21)
NET CASH PROVIDED BY (USED IN) FINANCING ACTIVITIES	(150)	3,120
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS	485	(5,527)
CASH AND CASH EQUIVALENTS, beginning of period	4,675	12,435
CASH AND CASH EQUIVALENTS, end of period	5,160	6,908
SUPPLEMENTAL CASH FLOW DISCLOSURES:
Income taxes paid	3	0
Interest paid on long-term debt	17	22
NON-CASH INVESTING AND FINANCING ACTIVITIES:
Issuance of common stock for acquisition	0	1,889
Unpaid consideration related to acquisitions	0	140
Transfer of equipment to inventory	69	34
Property, plant and equipment financed through accounts payable	$ 21	$ 310

XML 18 R7.htm IDEA: XBRL DOCUMENT

ORGANIZATION AND BACKGROUND	3 Months Ended
ORGANIZATION AND BACKGROUND	Sep. 30, 2017
Organization, Consolidation and Presentation of Financial Statements [Abstract]
ORGANIZATION AND BACKGROUND	ORGANIZATION AND BACKGROUND Organization: The accompanying unaudited condensed consolidated financial statements include the financial transactions and accounts of Sharps Compliance Corp. and its wholly owned subsidiaries, Sharps Compliance, Inc. of Texas (dba Sharps Compliance, Inc.), Sharps e-Tools.com Inc. (“Sharps e-Tools”), Sharps Manufacturing, Inc., Sharps Environmental Services, Inc. (dba Sharps Environmental Services of Texas, Inc.), Sharps Safety, Inc., Alpha Bio/Med Services LLC, Bio-Team Mobile LLC and Citiwaste, LLC (collectively, “Sharps” or the “Company”). All significant intercompany accounts and transactions have been eliminated upon consolidation. Business: Sharps is a leading full-service national provider of comprehensive waste management services including medical, pharmaceutical and hazardous for small and medium quantity generators. The Company’s solutions include Sharps Recovery System™ (formerly Sharps Disposal by Mail System^®), TakeAway Medication Recovery System™, MedSafe^®, TakeAway Recycle System™,ComplianceTRAC^SM, SharpsTracer^®, Sharps Secure^®Needle Disposal System, Complete Needle™ Collection & Disposal System, TakeAway Environmental Return System™, Pitch-It IV™ Poles, Asset Return System and Spill Kit and Recovery System. The Company also offers its route-based pick-up service in a twenty-three (23) state region of the South, Southeast and Northeast portions of the United States.

XML 19 R8.htm IDEA: XBRL DOCUMENT

BASIS OF PRESENTATION	3 Months Ended
BASIS OF PRESENTATION	Sep. 30, 2017
BASIS OF PRESENTATION [Abstract]
BASIS OF PRESENTATION	BASIS OF PRESENTATION The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with the rules and regulations of the Securities and Exchange Commission (“SEC”) for interim financial information and with instructions to Form 10-Q and, accordingly, do not include all information and footnotes required under generally accepted accounting principles in the United States of America ("GAAP") for complete financial statements. Additionally, the preparation of the condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect reported amounts. In the opinion of management, these interim condensed consolidated financial statements contain all adjustments (consisting of normal recurring adjustments) considered necessary for a fair presentation of the consolidated financial position of the Company as of September 30, 2017, the results of its operations for the three months ended September 30, 2017 and 2016, cash flows for the three months ended September 30, 2017 and 2016 and stockholders’ equity for the three months ended September 30, 2017. The results of operations for the three months ended September 30, 2017 are not necessarily indicative of the results to be expected for the entire fiscal year ending June 30, 2018. These unaudited condensed consolidated financial statements should be read in conjunction with the Company’s Annual Report on Form 10-K for the year ended June 30, 2017.

XML 20 R9.htm IDEA: XBRL DOCUMENT

SIGNIFICANT ACCOUNTING POLICIES	3 Months Ended
SIGNIFICANT ACCOUNTING POLICIES	Sep. 30, 2017
Accounting Policies [Abstract]
SIGNIFICANT ACCOUNTING POLICIES	SIGNIFICANT ACCOUNTING POLICIES Revenue Recognition: The Company recognizes revenue when services are provided and from product sales when (i) goods are shipped or delivered, and title and risk of loss pass to the customer, (ii) the price is substantially fixed or determinable and (iii) collectability is reasonably assured except for those sales via multiple-deliverable revenue arrangements. Provisions for certain rebates, product returns and discounts to customers are accounted for as reductions in sales in the same period the related sales are recorded. Product discounts granted are based on the terms of arrangements with direct, indirect and other market participants, as well as market conditions, including prices charged by competitors. Rebates are estimated based on contractual terms, historical experience, trend analysis and projected market conditions in the various markets served. Service agreements which include a vendor managed inventory program include terms that meet the “bill and hold” criteria and as such are recognized when the order is completed, at which point title has transferred, there are no acceptance provisions and amounts are segregated in the Company’s warehouse. During both the three months ended September 30, 2017 and 2016, the Company recorded revenue from inventory builds that are held in vendor managed inventory under these service agreements of $1.0 million. As of September 30, 2017 and June 30, 2017, $2.9 million and $2.7 million, respectively, of solutions sold through that date were held in vendor managed inventory pending fulfillment or shipment to patients of pharmaceutical manufacturers who offer these solutions to patients in an ongoing patient support program. Certain products offered by the Company have revenue producing components that are recognized over multiple delivery points (Sharps Recovery System and various other solutions like the TakeAway Medication Recovery Systems referred to as “Mailbacks” and Sharps Pump and Asset Return Systems, referred to as “Pump Returns”) and can consist of up to three separate elements, or units of measure, as follows: (1) the sale of the compliance and container system, (2) return transportation and (3) treatment service. In accordance with the relative selling price methodology, an estimated selling price is determined for all deliverables that qualify for separate units of accounting. The actual consideration received in a multiple-deliverable arrangement is then allocated to the units based on their relative sales price. The selling price for the transportation revenue and the treatment revenue utilizes third party evidence. The Company estimates the selling price of the compliance and container system based on the product and services, provided, including compliance with local, state and federal laws, adherence to stringent manufacturing and testing requirements, safety to the patient and the community as well as storage and containment capabilities. Revenue for the sale of the compliance and container is recognized upon delivery to the customer, at which time the customer takes title and assumes risk of ownership. Transportation revenue is recognized when the customer returns the compliance and container system and the container has been received at the Company’s owned or contracted facilities. The compliance and container system is mailed or delivered by an alternative logistics provider to the Company’s owned or contracted facilities. Treatment revenue is recognized upon the destruction or conversion and proof of receipt and treatment having been performed on the container. Since the transportation element and the treatment elements are undelivered services at the point of initial sale of the compliance and container, transportation and treatment revenue is deferred until the services are performed. The current and long-term portions of deferred revenues are determined through regression analysis and historical trends. Furthermore, through regression analysis of historical data, the Company has determined that a certain percentage of all compliance and container systems sold may not be returned. Accordingly, a portion of the transportation and treatment elements are recognized at the point of sale. Income Taxes: Deferred tax assets and liabilities are determined based on differences between financial reporting and tax bases of assets and liabilities and are measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse. A valuation allowance is established when it is more likely than not that some portion or all of the deferred tax assets will not be realized. The establishment of valuation allowances and development of projected annual effective tax rates requires significant judgment and is impacted by various estimates. Both positive and negative evidence, as well as the objectivity and verifiability of that evidence, is considered in determining the appropriateness of recording a valuation allowance on deferred tax assets. Under GAAP, the valuation allowance has been recorded to reduce the Company’s deferred tax assets to an amount that is more likely than not to be realized and is based upon the uncertainty of the realization of certain federal and state deferred tax assets related to net operating loss carryforwards and other tax attributes. Goodwill and Other Identifiable Intangible Assets: Finite-lived intangible assets are amortized over their respective estimated useful lives and evaluated for impairment periodically whenever events or changes in circumstances indicate that their related carrying values may not be fully recoverable. Goodwill is assessed for impairment at least annually. The Company generally performs its annual goodwill impairment analysis using a quantitative approach. The quantitative goodwill impairment test identifies the existence of potential impairment by comparing the fair value of our single reporting unit with its carrying value, including goodwill. If the fair value of a reporting unit exceeds its carrying value, the reporting unit's goodwill is considered not to be impaired. If the carrying value of a reporting unit exceeds its fair value, an impairment charge is recognized in an amount equal to that excess. The impairment charge recognized is limited to the amount of goodwill present in our single reporting unit. These estimates and assumptions could have a significant impact on whether or not an impairment charge is recognized and the amount of any such charge. The Company performs its annual impairment assessment of goodwill during the fourth quarter of each fiscal year. The Company determined that there was no impairment during the prior year ended June 30, 2017. Accounts Receivable: Accounts receivable consist primarily of amounts due to the Company from normal business activities. Accounts receivable balances are determined to be delinquent when the amount is past due based on the contractual terms with the customer. The Company maintains an allowance for doubtful accounts to reflect the likelihood of not collecting certain accounts receivable based on past collection history and specific risks identified among uncollected accounts. Accounts receivable are charged to the allowance for doubtful accounts when the Company determines that the receivable will not be collected and/or when the account has been referred to a third party collection agency. The Company has a history of minimal uncollectible accounts. Stock-Based Compensation: Stock-based compensation cost for options and restricted stock awarded to employees and directors is measured at the grant date, based on the calculated fair value of the award and is recognized as an expense over the requisite service period (generally the vesting period of the equity grant). Fair Value of Financial Instruments: The Company considers the fair value of all financial instruments, including cash and cash equivalents, accounts receivable and accounts payable to approximate their carrying values at September 30, 2017 and June 30, 2017 due to their short-term nature. The carrying value of the Company’s debt approximates fair value due to the market rates of interest.

XML 21 R10.htm IDEA: XBRL DOCUMENT

RECENTLY ISSUED ACCOUNTING STANDARDS	3 Months Ended
RECENTLY ISSUED ACCOUNTING STANDARDS	Sep. 30, 2017
New Accounting Pronouncements and Changes in Accounting Principles [Abstract]
RECENTLY ISSUED ACCOUNTING STANDARDS	RECENTLY ISSUED ACCOUNTING STANDARDS In May 2014, guidance for revenue recognition was issued which supersedes the revenue recognition requirements currently followed by the Company. The new guidance provides for a single five-step model to be applied in determining the amount and timing of the recognition of revenue related to contracts with customers. The new standard also requires additional financial statement disclosures that will enable users to understand the nature, amount, timing and uncertainty of revenue and cash flows relating to customer contracts. In March 2016, guidance for revenue from contracts with customers regarding principal versus agent considerations was issued which modified examples to assist in the application of the guidance. Companies have an option to use either a retrospective approach or cumulative effect adjustment approach to implement the standard. The guidance is effective for annual reporting periods beginning after December 15, 2017 (effective July 1, 2018 for the Company). The Company is in the initial stages of evaluating the impact that the new accounting guidance will have on its consolidated financial statements and related disclosures as well as evaluating the available transition methods. The Company will continue to evaluate the standard as well as additional changes, modifications or interpretations which may impact the Company. In February 2016, guidance for leases was issued, which requires balance sheet recognition for rights and obligations of all leases with terms in excess of twelve months. The new guidance also requires additional disclosures about the amount, timing and uncertainty of cash flows arising from leases. The provisions of the new guidance are effective for annual periods beginning after December 15, 2018 (effective July 1, 2019 for the Company), including interim periods within the reporting period, and early application is permitted. The Company is in the initial stages of evaluating the impact of the new guidance on its consolidated financial statements and related disclosures.

XML 22 R11.htm IDEA: XBRL DOCUMENT

INCOME TAXES	3 Months Ended
INCOME TAXES	Sep. 30, 2017
Income Tax Disclosure [Abstract]
INCOME TAXES	INCOME TAXES The Company’s net deferred tax assets have been fully reserved by a tax valuation allowance. The Company’s effective tax rate for the three months ended September 30, 2017 was 8.0% reflecting estimated state income taxes. The Company’s tax expense associated with taxable income during the three months ended September 30, 2017 was offset by the utilization of net operating loss carryforwards. No income tax expense was recorded for the three months ended September 30, 2016 as it was not material due to the valuation allowance and net operating losses.

XML 23 R12.htm IDEA: XBRL DOCUMENT

NOTES PAYABLE AND LONG-TERM DEBT

3 Months Ended

Sep. 30, 2017

Debt Disclosure [Abstract]

NOTES PAYABLE AND LONG-TERM DEBT

At September 30, 2017, long-term debt consisted of the following (in thousands):



Non-interest bearing, unsecured note payable assumed in acquisition, monthly payments of $7; maturing September 2018.	$	83

Term loan, bearing interest at 3.75%, monthly payments of $43; maturing March 2022.	2,370

Total long-term debt	2,453
Less: current portion	600
Long-term debt, net of current portion	$	1,853

Payments due on long-term debt during each of the five years subsequent to September 30, 2017 are as follows (in thousands):



Twelve Months Ending September 30,
2018	$	600
2019	517
2020	517
2021	517
2022	302
	$	2,453

XML 24 R13.htm IDEA: XBRL DOCUMENT

STOCK-BASED COMPENSATION

3 Months Ended

Sep. 30, 2017

Disclosure of Compensation Related Costs, Share-based Payments [Abstract]

STOCK-BASED COMPENSATION



	Three-Months Ended September 30,
	2017		2016
Stock-based compensation expense included in:
Cost of revenues	$	14	$	12
Selling, general and administrative	107		127
Total	$	121	$	139

- Definition

The entire disclosure for compensation-related costs for equity-based compensation, which may include disclosure of policies, compensation plan details, allocation of equity compensation, incentive distributions, equity-based arrangements to obtain goods and services, deferred compensation arrangements, employee stock ownership plan details and employee stock purchase plan details.

+ References + Details

XML 25 R14.htm IDEA: XBRL DOCUMENT

EARNINGS PER SHARE

3 Months Ended

Sep. 30, 2017

Earnings Per Share [Abstract]

EARNINGS PER SHARE

The following information is necessary to calculate earnings per share for the periods presented (in thousands, except per-share data):



	Three-Months Ended September 30,
	2017		2016
Net income (loss), as reported	$	75	$	(967	)

Weighted average common shares outstanding	16,008		15,868
Effect of dilutive stock options	85		—
Weighted average diluted common shares outstanding	16,093		15,868

Net income (loss) per common share
Basic and diluted	$	0.00	$	(0.06	)

Employee stock options excluded from computation of dilutive income per share amounts because their effect would be anti-dilutive	231		145

XML 26 R15.htm IDEA: XBRL DOCUMENT

EQUITY TRANSACTIONS

3 Months Ended

Sep. 30, 2017

Stockholders' Equity Note [Abstract]

EQUITY TRANSACTIONS

During the three months ended September 30, 2017 and 2016, stock options to purchase shares of the Company’s common stock were exercised as follows:



	Three-Months Ended September 30,
	2017		2016
Options Exercised	—		46,223
Proceeds (in thousands)	$	—	$	141
Average exercise price per share	$	—	$	3.05

- Definition

The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 310
-SubTopic 10
-Section S99
-Paragraph 4
-Subparagraph (SAB Topic 4.E)
-URI http://asc.fasb.org/extlink&oid=27010918&loc=d3e74567-122707

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21484-112644

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21488-112644

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(e))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(31))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 4
-Subparagraph (SAB Topic 4.C)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187143-122770

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(30))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21506-112644

Reference 10: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(d))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 11: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 12: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 30
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6405834&loc=d3e23285-112656

Reference 13: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21475-112644

Reference 14: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Preferred Stock
-URI http://asc.fasb.org/extlink&oid=6521494

Reference 15: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644

Reference 16: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 11
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21564-112644

+ Details

XML 27 R16.htm IDEA: XBRL DOCUMENT

GOODWILL AND INTANGIBLE ASSETS

3 Months Ended

Sep. 30, 2017

Goodwill and Intangible Assets Disclosure [Abstract]

GOODWILL AND INTANGIBLE ASSETS

At September 30, 2017 and June 30, 2017, intangible assets consisted of the following (in thousands):



		September 30, 2017							June 30, 2017
	Estimated Useful Lives	Original Amount		Accumulated Amortization			Net Amount		Original Amount		Accumulated Amortization			Net Amount
Customer relationships	7 years	$	3,007	$	(597	)	$	2,410	$	3,007	$	(490	)	$	2,517
Permits	6 - 15 years	1,414		(314		)	1,100		1,373		(288		)	1,085
Patents	5 - 17 years	383		(268		)	115		383		(264		)	119
Tradename	7 years	270		(48		)	222		270		(39		)	231
Non-compete	5 years	117		(29		)	88		117		(23		)	94
Total intangible assets, net		$	5,191	$	(1,256	)	$	3,935	$	5,150	$	(1,104	)	$	4,046

During both the three months ended September 30, 2017 and 2016, amortization expense was $0.2 million. There have been no changes in the carrying amount of goodwill since June 30, 2017.

As of September 30, 2017, future amortization of intangible assets is as follows (in thousands):



Twelve Months Ending September 30,
2018	606
2019	606
2020	606
2021	599
2022	571
Thereafter	947
	$	3,935

- Definition

The entire disclosure for the aggregate amount of goodwill and a description of intangible assets, which may include (a) for amortizable intangible assets (also referred to as finite-lived intangible assets), the carrying amount, the amount of any significant residual value, and the weighted-average amortization period, (b) for intangible assets not subject to amortization (also referred to as indefinite-lived intangible assets), the carrying amount, and (c) the amount of research and development assets acquired and written off in the period, including the line item in the income statement in which the amounts written off are aggregated, if not readily apparent from the income statement. Also discloses (a) for amortizable intangibles assets in total and by major class, the gross carrying amount and accumulated amortization, the total amortization expense for the period, and the estimated aggregate amortization expense for each of the five succeeding fiscal years, (b) for intangible assets not subject to amortization the carrying amount in total and by major class, and (c) for goodwill, in total and for each reportable segment, the changes in the carrying amount of goodwill during the period (including the aggregate amount of goodwill acquired, the aggregate amount of impairment losses recognized, and the amount of goodwill included in the gain (loss) on disposal of a reporting unit). If any part of goodwill has not been allocated to a reportable segment, discloses the unallocated amount and the reasons for not allocating. For each impairment loss recognized related to an intangible asset (excluding goodwill), discloses: (a) a description of the impaired intangible asset and the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method for determining fair value, (c) the caption in the income statement or the statement of activities in which the impairment loss is aggregated, and (d) the segment in which the impaired intangible asset is reported. For each goodwill impairment loss recognized, discloses: (a) a description of the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method of determining the fair value of the associated reporting unit, and (c) if a recognized impairment loss is an estimate not finalized and the reasons why the estimate is not final. May also disclose the nature and amount of any significant adjustments made to a previous estimate of an impairment loss.

+ References + Details

XML 28 R17.htm IDEA: XBRL DOCUMENT

INVENTORY

3 Months Ended

Sep. 30, 2017

Inventory Disclosure [Abstract]

INVENTORY

The components of inventory are as follows (in thousands):



	September 30, 2017		June 30, 2017
Raw materials	$	1,255	1,272
Finished goods	2,984		2,826
Total	$	4,239	4,098

XML 29 R18.htm IDEA: XBRL DOCUMENT

REVENUES BY SOLUTION

3 Months Ended

Sep. 30, 2017

Segment Reporting [Abstract]

REVENUES BY SOLUTION

The components of revenues by solution are as follows (in thousands):



	Three-Months Ended September 30,
	2017		% Total		2016		% Total
REVENUES BY SOLUTION:
Mailbacks	$	5,339	55.1	%	$	6,249	65.6	%
Route-based pickup services	1,761		18.2	%	1,465		15.4	%
Unused medications	1,172		12.1	%	791		8.3	%
Third party treatment services	434		4.5	%	68		0.7	%
Other ⁽¹⁾	977		10.1	%	958		10.0	%
Total revenues	$	9,683	100.0	%	$	9,531	100.0	%


(1)	The Company’s other products include non-mailback products such as IV poles, accessories, containers, asset return boxes and other miscellaneous items.

- Definition

The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 34
-URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8981-108599

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 41
-URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e9038-108599

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 33
-URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8971-108599

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 12
-URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8595-108599

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8380-108599

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8933-108599

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 26
-URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8844-108599

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 35
-URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8984-108599

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 40
-URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e9031-108599

Reference 10: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 42
-URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e9054-108599

Reference 11: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 10
-URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8538-108599

Reference 12: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 29
-URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8864-108599

Reference 13: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 31
-URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8924-108599

Reference 14: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8906-108599

+ Details

XML 30 R19.htm IDEA: XBRL DOCUMENT

SIGNIFICANT ACCOUNTING POLICIES (Policies)	3 Months Ended
SIGNIFICANT ACCOUNTING POLICIES (Policies)	Sep. 30, 2017
Accounting Policies [Abstract]
Revenue Recognition	Revenue Recognition: The Company recognizes revenue when services are provided and from product sales when (i) goods are shipped or delivered, and title and risk of loss pass to the customer, (ii) the price is substantially fixed or determinable and (iii) collectability is reasonably assured except for those sales via multiple-deliverable revenue arrangements. Provisions for certain rebates, product returns and discounts to customers are accounted for as reductions in sales in the same period the related sales are recorded. Product discounts granted are based on the terms of arrangements with direct, indirect and other market participants, as well as market conditions, including prices charged by competitors. Rebates are estimated based on contractual terms, historical experience, trend analysis and projected market conditions in the various markets served. Service agreements which include a vendor managed inventory program include terms that meet the “bill and hold” criteria and as such are recognized when the order is completed, at which point title has transferred, there are no acceptance provisions and amounts are segregated in the Company’s warehouse. During both the three months ended September 30, 2017 and 2016, the Company recorded revenue from inventory builds that are held in vendor managed inventory under these service agreements of $1.0 million. As of September 30, 2017 and June 30, 2017, $2.9 million and $2.7 million, respectively, of solutions sold through that date were held in vendor managed inventory pending fulfillment or shipment to patients of pharmaceutical manufacturers who offer these solutions to patients in an ongoing patient support program. Certain products offered by the Company have revenue producing components that are recognized over multiple delivery points (Sharps Recovery System and various other solutions like the TakeAway Medication Recovery Systems referred to as “Mailbacks” and Sharps Pump and Asset Return Systems, referred to as “Pump Returns”) and can consist of up to three separate elements, or units of measure, as follows: (1) the sale of the compliance and container system, (2) return transportation and (3) treatment service. In accordance with the relative selling price methodology, an estimated selling price is determined for all deliverables that qualify for separate units of accounting. The actual consideration received in a multiple-deliverable arrangement is then allocated to the units based on their relative sales price. The selling price for the transportation revenue and the treatment revenue utilizes third party evidence. The Company estimates the selling price of the compliance and container system based on the product and services, provided, including compliance with local, state and federal laws, adherence to stringent manufacturing and testing requirements, safety to the patient and the community as well as storage and containment capabilities. Revenue for the sale of the compliance and container is recognized upon delivery to the customer, at which time the customer takes title and assumes risk of ownership. Transportation revenue is recognized when the customer returns the compliance and container system and the container has been received at the Company’s owned or contracted facilities. The compliance and container system is mailed or delivered by an alternative logistics provider to the Company’s owned or contracted facilities. Treatment revenue is recognized upon the destruction or conversion and proof of receipt and treatment having been performed on the container. Since the transportation element and the treatment elements are undelivered services at the point of initial sale of the compliance and container, transportation and treatment revenue is deferred until the services are performed. The current and long-term portions of deferred revenues are determined through regression analysis and historical trends. Furthermore, through regression analysis of historical data, the Company has determined that a certain percentage of all compliance and container systems sold may not be returned. Accordingly, a portion of the transportation and treatment elements are recognized at the point of sale.
Business Combinations
Income Taxes	Income Taxes: Deferred tax assets and liabilities are determined based on differences between financial reporting and tax bases of assets and liabilities and are measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse. A valuation allowance is established when it is more likely than not that some portion or all of the deferred tax assets will not be realized. The establishment of valuation allowances and development of projected annual effective tax rates requires significant judgment and is impacted by various estimates. Both positive and negative evidence, as well as the objectivity and verifiability of that evidence, is considered in determining the appropriateness of recording a valuation allowance on deferred tax assets. Under GAAP, the valuation allowance has been recorded to reduce the Company’s deferred tax assets to an amount that is more likely than not to be realized and is based upon the uncertainty of the realization of certain federal and state deferred tax assets related to net operating loss carryforwards and other tax attributes.
Goodwill and Other Identifiable Intangible Assets	Goodwill and Other Identifiable Intangible Assets: Finite-lived intangible assets are amortized over their respective estimated useful lives and evaluated for impairment periodically whenever events or changes in circumstances indicate that their related carrying values may not be fully recoverable. Goodwill is assessed for impairment at least annually. The Company generally performs its annual goodwill impairment analysis using a quantitative approach. The quantitative goodwill impairment test identifies the existence of potential impairment by comparing the fair value of our single reporting unit with its carrying value, including goodwill. If the fair value of a reporting unit exceeds its carrying value, the reporting unit's goodwill is considered not to be impaired. If the carrying value of a reporting unit exceeds its fair value, an impairment charge is recognized in an amount equal to that excess. The impairment charge recognized is limited to the amount of goodwill present in our single reporting unit. These estimates and assumptions could have a significant impact on whether or not an impairment charge is recognized and the amount of any such charge. The Company performs its annual impairment assessment of goodwill during the fourth quarter of each fiscal year.
Accounts Receivable	Accounts Receivable: Accounts receivable consist primarily of amounts due to the Company from normal business activities. Accounts receivable balances are determined to be delinquent when the amount is past due based on the contractual terms with the customer. The Company maintains an allowance for doubtful accounts to reflect the likelihood of not collecting certain accounts receivable based on past collection history and specific risks identified among uncollected accounts. Accounts receivable are charged to the allowance for doubtful accounts when the Company determines that the receivable will not be collected and/or when the account has been referred to a third party collection agency. The Company has a history of minimal uncollectible accounts.
Stock-Based Compensation	Stock-Based Compensation: Stock-based compensation cost for options and restricted stock awarded to employees and directors is measured at the grant date, based on the calculated fair value of the award and is recognized as an expense over the requisite service period (generally the vesting period of the equity grant).
Fair Value of Financial Instruments	Fair Value of Financial Instruments: The Company considers the fair value of all financial instruments, including cash and cash equivalents, accounts receivable and accounts payable to approximate their carrying values at September 30, 2017 and June 30, 2017 due to their short-term nature. The carrying value of the Company’s debt approximates fair value due to the market rates of interest.
New Accounting Pronouncement	In May 2014, guidance for revenue recognition was issued which supersedes the revenue recognition requirements currently followed by the Company. The new guidance provides for a single five-step model to be applied in determining the amount and timing of the recognition of revenue related to contracts with customers. The new standard also requires additional financial statement disclosures that will enable users to understand the nature, amount, timing and uncertainty of revenue and cash flows relating to customer contracts. In March 2016, guidance for revenue from contracts with customers regarding principal versus agent considerations was issued which modified examples to assist in the application of the guidance. Companies have an option to use either a retrospective approach or cumulative effect adjustment approach to implement the standard. The guidance is effective for annual reporting periods beginning after December 15, 2017 (effective July 1, 2018 for the Company). The Company is in the initial stages of evaluating the impact that the new accounting guidance will have on its consolidated financial statements and related disclosures as well as evaluating the available transition methods. The Company will continue to evaluate the standard as well as additional changes, modifications or interpretations which may impact the Company. In February 2016, guidance for leases was issued, which requires balance sheet recognition for rights and obligations of all leases with terms in excess of twelve months. The new guidance also requires additional disclosures about the amount, timing and uncertainty of cash flows arising from leases. The provisions of the new guidance are effective for annual periods beginning after December 15, 2018 (effective July 1, 2019 for the Company), including interim periods within the reporting period, and early application is permitted. The Company is in the initial stages of evaluating the impact of the new guidance on its consolidated financial statements and related disclosures.

- Definition

Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.

+ References + Details

- Definition

Disclosure of accounting policy for trade and other accounts receivable, and finance, loan and lease receivables, including those classified as held for investment and held for sale. This disclosure may include (1) the basis at which such receivables are carried in the entity's statements of financial position (2) how the level of the valuation allowance for receivables is determined (3) when impairments, charge-offs or recoveries are recognized for such receivables (4) the treatment of origination fees and costs, including the amortization method for net deferred fees or costs (5) the treatment of any premiums or discounts or unearned income (6) the entity's income recognition policies for such receivables, including those that are impaired, past due or placed on nonaccrual status and (7) the treatment of foreclosures or repossessions (8) the nature and amount of any guarantees to repurchase receivables.

+ References + Details

XML 31 R20.htm IDEA: XBRL DOCUMENT

NOTES PAYABLE AND LONG-TERM DEBT (Tables)

3 Months Ended

Sep. 30, 2017

Debt Disclosure [Abstract]

Schedule of long-term debt

At September 30, 2017, long-term debt consisted of the following (in thousands):



Non-interest bearing, unsecured note payable assumed in acquisition, monthly payments of $7; maturing September 2018.	$	83

Term loan, bearing interest at 3.75%, monthly payments of $43; maturing March 2022.	2,370

Total long-term debt	2,453
Less: current portion	600
Long-term debt, net of current portion	$	1,853

Schedule of payments due on long-term debt

Payments due on long-term debt during each of the five years subsequent to September 30, 2017 are as follows (in thousands):



Twelve Months Ending September 30,
2018	$	600
2019	517
2020	517
2021	517
2022	302
	$	2,453

- Definition

Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.22)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21475-112644

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 470
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=6479336&loc=d3e64711-112823

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(e),(f))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 55
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=64930739&loc=d3e28878-108400

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21538-112644

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21506-112644

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 45
-Paragraph 1A
-URI http://asc.fasb.org/extlink&oid=64930785&loc=d3e28541-108399

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=64930785&loc=d3e28551-108399

Reference 10: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 7
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21521-112644

+ Details

XML 32 R21.htm IDEA: XBRL DOCUMENT

STOCK-BASED COMPENSATION (Tables)

3 Months Ended

Sep. 30, 2017

Disclosure of Compensation Related Costs, Share-based Payments [Abstract]

Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table Text Block]

During the three months ended September 30, 2017 and 2016, stock-based compensation amounts are as follows (in thousands):



	Three-Months Ended September 30,
	2017		2016
Stock-based compensation expense included in:
Cost of revenues	$	14	$	12
Selling, general and administrative	107		127
Total	$	121	$	139

XML 33 R22.htm IDEA: XBRL DOCUMENT

EARNINGS PER SHARE (Tables)

3 Months Ended

Sep. 30, 2017

Earnings Per Share [Abstract]

Schedule of Earnings Per Share

The following information is necessary to calculate earnings per share for the periods presented (in thousands, except per-share data):



	Three-Months Ended September 30,
	2017		2016
Net income (loss), as reported	$	75	$	(967	)

Weighted average common shares outstanding	16,008		15,868
Effect of dilutive stock options	85		—
Weighted average diluted common shares outstanding	16,093		15,868

Net income (loss) per common share
Basic and diluted	$	0.00	$	(0.06	)

Employee stock options excluded from computation of dilutive income per share amounts because their effect would be anti-dilutive	231		145

XML 34 R23.htm IDEA: XBRL DOCUMENT

EQUITY TRANSACTIONS (Tables)

3 Months Ended

Sep. 30, 2017

Stockholders' Equity Note [Abstract]

Stock options exercised to purchase common stock

During the three months ended September 30, 2017 and 2016, stock options to purchase shares of the Company’s common stock were exercised as follows:



	Three-Months Ended September 30,
	2017		2016
Options Exercised	—		46,223
Proceeds (in thousands)	$	—	$	141
Average exercise price per share	$	—	$	3.05

XML 35 R24.htm IDEA: XBRL DOCUMENT

GOODWILL AND INTANGIBLE ASSETS (Tables)

3 Months Ended

Sep. 30, 2017

Goodwill and Intangible Assets Disclosure [Abstract]

Schedule of intangible assets

At September 30, 2017 and June 30, 2017, intangible assets consisted of the following (in thousands):



		September 30, 2017							June 30, 2017
	Estimated Useful Lives	Original Amount		Accumulated Amortization			Net Amount		Original Amount		Accumulated Amortization			Net Amount
Customer relationships	7 years	$	3,007	$	(597	)	$	2,410	$	3,007	$	(490	)	$	2,517
Permits	6 - 15 years	1,414		(314		)	1,100		1,373		(288		)	1,085
Patents	5 - 17 years	383		(268		)	115		383		(264		)	119
Tradename	7 years	270		(48		)	222		270		(39		)	231
Non-compete	5 years	117		(29		)	88		117		(23		)	94
Total intangible assets, net		$	5,191	$	(1,256	)	$	3,935	$	5,150	$	(1,104	)	$	4,046

Schedule of future amortization of intangible assets

As of September 30, 2017, future amortization of intangible assets is as follows (in thousands):



Twelve Months Ending September 30,
2018	606
2019	606
2020	606
2021	599
2022	571
Thereafter	947
	$	3,935

XML 36 R25.htm IDEA: XBRL DOCUMENT

INVENTORY (Tables)

3 Months Ended

Sep. 30, 2017

Inventory Disclosure [Abstract]

Schedule of Inventory

The components of inventory are as follows (in thousands):



	September 30, 2017		June 30, 2017
Raw materials	$	1,255	1,272
Finished goods	2,984		2,826
Total	$	4,239	4,098

XML 37 R26.htm IDEA: XBRL DOCUMENT

REVENUES BY SOLUTION (Tables)

3 Months Ended

Sep. 30, 2017

Segment Reporting [Abstract]

Schedule of billings by solution

The components of revenues by solution are as follows (in thousands):



	Three-Months Ended September 30,
	2017		% Total		2016		% Total
REVENUES BY SOLUTION:
Mailbacks	$	5,339	55.1	%	$	6,249	65.6	%
Route-based pickup services	1,761		18.2	%	1,465		15.4	%
Unused medications	1,172		12.1	%	791		8.3	%
Third party treatment services	434		4.5	%	68		0.7	%
Other ⁽¹⁾	977		10.1	%	958		10.0	%
Total revenues	$	9,683	100.0	%	$	9,531	100.0	%


(1)	The Company’s other products include non-mailback products such as IV poles, accessories, containers, asset return boxes and other miscellaneous items.

XML 38 R27.htm IDEA: XBRL DOCUMENT

ORGANIZATION AND BACKGROUND (Details)	3 Months Ended
ORGANIZATION AND BACKGROUND (Details)	Sep. 30, 2017 state_region
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Number of route-based pick-up service in state region	23

XML 39 R28.htm IDEA: XBRL DOCUMENT

SIGNIFICANT ACCOUNTING POLICIES (Details) - USD ($) $ in Millions	3 Months Ended
	Sep. 30, 2017	Sep. 30, 2016	Jun. 30, 2017
Revenue Recognition [Abstract]
Revenue recorded from inventory builds	$ 1.0	$ 1.0
Solutions sold that were held in vendor managed inventory	$ 2.9		$ 2.7

XML 40 R29.htm IDEA: XBRL DOCUMENT

INCOME TAXES (Details) - USD ($)	3 Months Ended
INCOME TAXES (Details) - USD ($)	Sep. 30, 2017	Sep. 30, 2016
Income Tax Disclosure [Abstract]
Income tax expense	$ 7,000	$ 0
Effective income tax rate	8.00%

XML 41 R30.htm IDEA: XBRL DOCUMENT

NOTES PAYABLE AND LONG-TERM DEBT - Narrative (Details)	3 Months Ended
NOTES PAYABLE AND LONG-TERM DEBT - Narrative (Details)	Sep. 30, 2017 USD ($)
Performance bonds
Line of Credit Facility [Line Items]
Performance bonds outstanding, financial assurance	$ 600,000.0
Term Loan
Line of Credit Facility [Line Items]
Maturity period	5 years
Interest rate	3.75%
Credit Agreement
Line of Credit Facility [Line Items]
Maximum borrowing capacity	$ 14,000,000.0
Percentage of eligible accounts receivable considered for borrowing base	80.00%
Percentage of eligible inventory considered for borrowing base	50.00%
Borrowing base, monetary benchmark	$ 3,000,000
Basis spread of variable rate	0.00%
Unused capacity, commitment fee percentage	0.25%
Remaining borrowing capacity	$ 11,600,000
Credit Agreement \| Minimum
Line of Credit Facility [Line Items]
Debt service coverage ratio	1.15
Credit Agreement \| Maximum
Line of Credit Facility [Line Items]
Debt cash flow leverage ratio	3.50
Debt cash flow of leverage ratio as on December 31, 2017	3.25
Decrease in cash flow of leverage ratio as on March 31, 2018	3.0
Credit Agreement \| Working Capital
Line of Credit Facility [Line Items]
Maximum borrowing capacity	$ 6,000,000.0
Remaining borrowing capacity	6,000,000
Credit Agreement \| Letter of Credit
Line of Credit Facility [Line Items]
Maximum borrowing capacity	2,000,000.0
Amount outstanding	10,000
Credit Agreement \| Acquisitions
Line of Credit Facility [Line Items]
Maximum borrowing capacity	$ 8,000,000.0
Percentage of portion allocated to acquisition purchase price	75.00%
Remaining borrowing capacity	$ 5,600,000
Credit Agreement \| LIBOR
Line of Credit Facility [Line Items]
Basis spread of variable rate	2.50%
Debt instrument, term of variable rate	1 month
Credit Agreement \| LIBOR \| Maximum
Line of Credit Facility [Line Items]
Basis spread of variable rate	3.00%

XML 42 R31.htm IDEA: XBRL DOCUMENT

NOTES PAYABLE AND LONG-TERM DEBT - Schedule of debt instruments (Details) - USD ($) $ in Thousands	3 Months Ended
	Sep. 30, 2017	Jun. 30, 2017
Long-term Debt, Unclassified [Abstract]
Total long-term debt	$ 2,453
Less: current portion	600	$ 601
Long-term debt, net of current portion	1,853	$ 2,002
Unsecured Note Payable
Long-term Debt, Unclassified [Abstract]
Monthly payments	7
Total long-term debt	83
Term Loan
Long-term Debt, Unclassified [Abstract]
Monthly payments	$ 43
Interest rate	3.75%
Total long-term debt	$ 2,370

XML 43 R32.htm IDEA: XBRL DOCUMENT

NOTES PAYABLE AND LONG-TERM DEBT - Schedule of payments due on long-term debt (Details) $ in Thousands	Sep. 30, 2017 USD ($)
Long-term Debt, Fiscal Year Maturity [Abstract]
2018	$ 600
2019	517
2020	517
2021	517
2022	302
Total long-term debt	$ 2,453

XML 44 R33.htm IDEA: XBRL DOCUMENT

STOCK-BASED COMPENSATION (Details) - USD ($) $ in Thousands	3 Months Ended
STOCK-BASED COMPENSATION (Details) - USD ($) $ in Thousands	Sep. 30, 2017	Sep. 30, 2016
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Stock-based compensation expense	$ 121	$ 139
Cost of revenues
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Stock-based compensation expense	14	12
Selling, general and administrative
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Stock-based compensation expense	$ 107	$ 127

XML 45 R34.htm IDEA: XBRL DOCUMENT

EARNINGS PER SHARE (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended		12 Months Ended
	Sep. 30, 2017	Sep. 30, 2016	Jun. 30, 2017
Earnings Per Share [Abstract]
Net income (loss), as reported	$ 75	$ (967)	$ (1,293)
Weighted average common shares outstanding (in shares)	16,008	15,868
Effect of dilutive stock options (in shares)	85	0
Weighted average diluted common shares outstanding (in shares)	16,093	15,868
Net income (loss) per common share
Basic and diluted (in dollars per share)	$ 0.00	$ (0.06)
Employee stock options excluded from computation of dilutive income per share amounts because their effect would be anti-dilutive (in shares)	231	145

XML 46 R35.htm IDEA: XBRL DOCUMENT

EQUITY TRANSACTIONS (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended
	Sep. 30, 2017	Sep. 30, 2016
Stock options exercised [Abstract]
Options exercised (in shares)	0	46,223
Proceeds from stock options exercised	$ 0	$ 141
Average exercise price per share (in dollars per share)	$ 0	$ 3.05
Compensation expense related to non-vested awards	$ 300
Weighted average period	2 years 7 months 15 days

XML 47 R36.htm IDEA: XBRL DOCUMENT

GOODWILL AND INTANGIBLE ASSETS (Details) - USD ($)	3 Months Ended
GOODWILL AND INTANGIBLE ASSETS (Details) - USD ($)	Sep. 30, 2017	Jun. 30, 2017
Finite-Lived Intangible Assets [Line Items]
Original Amount	$ 5,191,000	$ 5,150,000
Accumulated Amortization	(1,256,000)	(1,104,000)
Net Amount	3,935,000	4,046,000
Intangible assets, amortization expense	200,000
Changes in goodwill	0
Future amortization of intangible assets [Abstract]
2018	606,000
2019	606,000
2020	606,000
2021	599,000
2022	571,000
Thereafter	947,000
Net Amount	$ 3,935,000	4,046,000
Customer relationships
Finite-Lived Intangible Assets [Line Items]
Estimated Useful Lives	7 years
Original Amount	$ 3,007,000	3,007,000
Accumulated Amortization	(597,000)	(490,000)
Net Amount	2,410,000	2,517,000
Future amortization of intangible assets [Abstract]
Net Amount	2,410,000	2,517,000
Permits
Finite-Lived Intangible Assets [Line Items]
Original Amount	1,414,000	1,373,000
Accumulated Amortization	(314,000)	(288,000)
Net Amount	1,100,000	1,085,000
Future amortization of intangible assets [Abstract]
Net Amount	$ 1,100,000	1,085,000
Permits \| Minimum
Finite-Lived Intangible Assets [Line Items]
Estimated Useful Lives	6 years
Permits \| Maximum
Finite-Lived Intangible Assets [Line Items]
Estimated Useful Lives	15 years
Patents
Finite-Lived Intangible Assets [Line Items]
Original Amount	$ 383,000	383,000
Accumulated Amortization	(268,000)	(264,000)
Net Amount	115,000	119,000
Future amortization of intangible assets [Abstract]
Net Amount	$ 115,000	119,000
Patents \| Minimum
Finite-Lived Intangible Assets [Line Items]
Estimated Useful Lives	5 years
Patents \| Maximum
Finite-Lived Intangible Assets [Line Items]
Estimated Useful Lives	17 years
Tradename
Finite-Lived Intangible Assets [Line Items]
Estimated Useful Lives	7 years
Original Amount	$ 270,000	270,000
Accumulated Amortization	(48,000)	(39,000)
Net Amount	222,000	231,000
Future amortization of intangible assets [Abstract]
Net Amount	$ 222,000	231,000
Non-compete
Finite-Lived Intangible Assets [Line Items]
Estimated Useful Lives	5 years
Original Amount	$ 117,000	117,000
Accumulated Amortization	(29,000)	(23,000)
Net Amount	88,000	94,000
Future amortization of intangible assets [Abstract]
Net Amount	$ 88,000	$ 94,000

XML 48 R37.htm IDEA: XBRL DOCUMENT

INVENTORY (Details) - USD ($) $ in Thousands	Sep. 30, 2017	Jun. 30, 2017
Components of inventory [Abstract]
Raw materials	$ 1,255	$ 1,272
Finished goods	2,984	2,826
Total	$ 4,239	$ 4,098

XML 49 R38.htm IDEA: XBRL DOCUMENT

REVENUES BY SOLUTION (Details) - USD ($) $ in Thousands	3 Months Ended
REVENUES BY SOLUTION (Details) - USD ($) $ in Thousands	Sep. 30, 2017	Sep. 30, 2016
Segment Reporting Information [Line Items]
Revenue reported	$ 9,683	$ 9,531
Revenue percentage	100.00%	100.00%
Mailbacks
Segment Reporting Information [Line Items]
Revenue reported	$ 5,339	$ 6,249
Revenue percentage	55.10%	65.60%
Route-based pickup services
Segment Reporting Information [Line Items]
Revenue reported	$ 1,761	$ 1,465
Revenue percentage	18.20%	15.40%
Unused medications
Segment Reporting Information [Line Items]
Revenue reported	$ 1,172	$ 791
Revenue percentage	12.10%	8.30%
Third party treatment services
Segment Reporting Information [Line Items]
Revenue reported	$ 434	$ 68
Revenue percentage	4.50%	0.70%
Other
Segment Reporting Information [Line Items]
Revenue reported	$ 977	$ 958
Revenue percentage	10.10%	10.00%

EXCEL 50 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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�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end XML 51 Show.js IDEA: XBRL DOCUMENT /** * Rivet Software Inc. * * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved. * Version 2.4.0.3 * */ var Show = {}; Show.LastAR = null, Show.hideAR = function(){ Show.LastAR.style.display = 'none'; }; Show.showAR = function ( link, id, win ){ if( Show.LastAR ){ Show.hideAR(); } var ref = link; do { ref = ref.nextSibling; } while (ref && ref.nodeName != 'TABLE'); if (!ref || ref.nodeName != 'TABLE') { var tmp = win ? win.document.getElementById(id) : document.getElementById(id); if( tmp ){ ref = tmp.cloneNode(true); ref.id = ''; link.parentNode.appendChild(ref); } } if( ref ){ ref.style.display = 'block'; Show.LastAR = ref; } }; Show.toggleNext = function( link ){ var ref = link; do{ ref = ref.nextSibling; }while( ref.nodeName != 'DIV' ); if( ref.style && ref.style.display && ref.style.display == 'none' ){ ref.style.display = 'block'; if( link.textContent ){ link.textContent = link.textContent.replace( '+', '-' ); }else{ link.innerText = link.innerText.replace( '+', '-' ); } }else{ ref.style.display = 'none'; if( link.textContent ){ link.textContent = link.textContent.replace( '-', '+' ); }else{ link.innerText = link.innerText.replace( '-', '+' ); } } }; XML 52 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 54 FilingSummary.xml IDEA: XBRL DOCUMENT 3.8.0.1 html 71 166 1 false 26 0 false 5 false false R1.htm 0001000 - Document - Document and Entity Information Sheet http://www.sharpsinc.com/role/DocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 1001000 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) Sheet http://www.sharpsinc.com/role/CondensedConsolidatedBalanceSheetsUnaudited CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) Statements 2 false false R3.htm 1001501 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical) Sheet http://www.sharpsinc.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical) Statements 3 false false R4.htm 1002000 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) Sheet http://www.sharpsinc.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) Statements 4 false false R5.htm 1003000 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Unaudited) Sheet http://www.sharpsinc.com/role/CondensedConsolidatedStatementsOfStockholdersEquityUnaudited CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Unaudited) Statements 5 false false R6.htm 1004000 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) Sheet http://www.sharpsinc.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) Statements 6 false false R7.htm 2101100 - Disclosure - ORGANIZATION AND BACKGROUND Sheet http://www.sharpsinc.com/role/OrganizationAndBackground ORGANIZATION AND BACKGROUND Notes 7 false false R8.htm 2102100 - Disclosure - BASIS OF PRESENTATION Sheet http://www.sharpsinc.com/role/BasisOfPresentation BASIS OF PRESENTATION Notes 8 false false R9.htm 2103100 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES Sheet http://www.sharpsinc.com/role/SignificantAccountingPolicies SIGNIFICANT ACCOUNTING POLICIES Notes 9 false false R10.htm 2104100 - Disclosure - RECENTLY ISSUED ACCOUNTING STANDARDS Sheet http://www.sharpsinc.com/role/RecentlyIssuedAccountingStandards RECENTLY ISSUED ACCOUNTING STANDARDS Notes 10 false false R11.htm 2105100 - Disclosure - INCOME TAXES Sheet http://www.sharpsinc.com/role/IncomeTaxes INCOME TAXES Notes 11 false false R12.htm 2106100 - Disclosure - NOTES PAYABLE AND LONG-TERM DEBT Notes http://www.sharpsinc.com/role/NotesPayableAndLongTermDebt NOTES PAYABLE AND LONG-TERM DEBT Notes 12 false false R13.htm 2107100 - Disclosure - STOCK-BASED COMPENSATION Sheet http://www.sharpsinc.com/role/StockBasedCompensation STOCK-BASED COMPENSATION Notes 13 false false R14.htm 2108100 - Disclosure - EARNINGS PER SHARE Sheet http://www.sharpsinc.com/role/EarningsPerShare EARNINGS PER SHARE Notes 14 false false R15.htm 2109100 - Disclosure - EQUITY TRANSACTIONS Sheet http://www.sharpsinc.com/role/EquityTransactions EQUITY TRANSACTIONS Notes 15 false false R16.htm 2110100 - Disclosure - GOODWILL AND INTANGIBLE ASSETS Sheet http://www.sharpsinc.com/role/GoodwillAndIntangibleAssets GOODWILL AND INTANGIBLE ASSETS Notes 16 false false R17.htm 2111100 - Disclosure - INVENTORY Sheet http://www.sharpsinc.com/role/Inventory INVENTORY Notes 17 false false R18.htm 2112100 - Disclosure - REVENUES BY SOLUTION Sheet http://www.sharpsinc.com/role/RevenuesBySolution REVENUES BY SOLUTION Notes 18 false false R19.htm 2203201 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Policies) Sheet http://www.sharpsinc.com/role/SignificantAccountingPoliciesPolicies SIGNIFICANT ACCOUNTING POLICIES (Policies) Policies 19 false false R20.htm 2306301 - Disclosure - NOTES PAYABLE AND LONG-TERM DEBT (Tables) Notes http://www.sharpsinc.com/role/NotesPayableAndLongTermDebtTables NOTES PAYABLE AND LONG-TERM DEBT (Tables) Tables http://www.sharpsinc.com/role/NotesPayableAndLongTermDebt 20 false false R21.htm 2307301 - Disclosure - STOCK-BASED COMPENSATION (Tables) Sheet http://www.sharpsinc.com/role/StockBasedCompensationTables STOCK-BASED COMPENSATION (Tables) Tables http://www.sharpsinc.com/role/StockBasedCompensation 21 false false R22.htm 2308301 - Disclosure - EARNINGS PER SHARE (Tables) Sheet http://www.sharpsinc.com/role/EarningsPerShareTables EARNINGS PER SHARE (Tables) Tables http://www.sharpsinc.com/role/EarningsPerShare 22 false false R23.htm 2309301 - Disclosure - EQUITY TRANSACTIONS (Tables) Sheet http://www.sharpsinc.com/role/EquityTransactionsTables EQUITY TRANSACTIONS (Tables) Tables http://www.sharpsinc.com/role/EquityTransactions 23 false false R24.htm 2310301 - Disclosure - GOODWILL AND INTANGIBLE ASSETS (Tables) Sheet http://www.sharpsinc.com/role/GoodwillAndIntangibleAssetsTables GOODWILL AND INTANGIBLE ASSETS (Tables) Tables http://www.sharpsinc.com/role/GoodwillAndIntangibleAssets 24 false false R25.htm 2311301 - Disclosure - INVENTORY (Tables) Sheet http://www.sharpsinc.com/role/InventoryTables INVENTORY (Tables) Tables http://www.sharpsinc.com/role/Inventory 25 false false R26.htm 2312301 - Disclosure - REVENUES BY SOLUTION (Tables) Sheet http://www.sharpsinc.com/role/RevenuesBySolutionTables REVENUES BY SOLUTION (Tables) Tables http://www.sharpsinc.com/role/RevenuesBySolution 26 false false R27.htm 2401401 - Disclosure - ORGANIZATION AND BACKGROUND (Details) Sheet http://www.sharpsinc.com/role/OrganizationAndBackgroundDetails ORGANIZATION AND BACKGROUND (Details) Details http://www.sharpsinc.com/role/OrganizationAndBackground 27 false false R28.htm 2403402 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Details) Sheet http://www.sharpsinc.com/role/SignificantAccountingPoliciesDetails SIGNIFICANT ACCOUNTING POLICIES (Details) Details http://www.sharpsinc.com/role/SignificantAccountingPoliciesPolicies 28 false false R29.htm 2405401 - Disclosure - INCOME TAXES (Details) Sheet http://www.sharpsinc.com/role/IncomeTaxesDetails INCOME TAXES (Details) Details http://www.sharpsinc.com/role/IncomeTaxes 29 false false R30.htm 2406402 - Disclosure - NOTES PAYABLE AND LONG-TERM DEBT - Narrative (Details) Notes http://www.sharpsinc.com/role/NotesPayableAndLongTermDebtNarrativeDetails NOTES PAYABLE AND LONG-TERM DEBT - Narrative (Details) Details 30 false false R31.htm 2406403 - Disclosure - NOTES PAYABLE AND LONG-TERM DEBT - Schedule of debt instruments (Details) Notes http://www.sharpsinc.com/role/NotesPayableAndLongTermDebtScheduleOfDebtInstrumentsDetails NOTES PAYABLE AND LONG-TERM DEBT - Schedule of debt instruments (Details) Details 31 false false R32.htm 2406404 - Disclosure - NOTES PAYABLE AND LONG-TERM DEBT - Schedule of payments due on long-term debt (Details) Notes http://www.sharpsinc.com/role/NotesPayableAndLongTermDebtScheduleOfPaymentsDueOnLongTermDebtDetails NOTES PAYABLE AND LONG-TERM DEBT - Schedule of payments due on long-term debt (Details) Details 32 false false R33.htm 2407402 - Disclosure - STOCK-BASED COMPENSATION (Details) Sheet http://www.sharpsinc.com/role/StockBasedCompensationDetails STOCK-BASED COMPENSATION (Details) Details http://www.sharpsinc.com/role/StockBasedCompensationTables 33 false false R34.htm 2408402 - Disclosure - EARNINGS PER SHARE (Details) Sheet http://www.sharpsinc.com/role/EarningsPerShareDetails EARNINGS PER SHARE (Details) Details http://www.sharpsinc.com/role/EarningsPerShareTables 34 false false R35.htm 2409402 - Disclosure - EQUITY TRANSACTIONS (Details) Sheet http://www.sharpsinc.com/role/EquityTransactionsDetails EQUITY TRANSACTIONS (Details) Details http://www.sharpsinc.com/role/EquityTransactionsTables 35 false false R36.htm 2410402 - Disclosure - GOODWILL AND INTANGIBLE ASSETS (Details) Sheet http://www.sharpsinc.com/role/GoodwillAndIntangibleAssetsDetails GOODWILL AND INTANGIBLE ASSETS (Details) Details http://www.sharpsinc.com/role/GoodwillAndIntangibleAssetsTables 36 false false R37.htm 2411402 - Disclosure - INVENTORY (Details) Sheet http://www.sharpsinc.com/role/InventoryDetails INVENTORY (Details) Details http://www.sharpsinc.com/role/InventoryTables 37 false false R38.htm 2412402 - Disclosure - REVENUES BY SOLUTION (Details) Sheet http://www.sharpsinc.com/role/RevenuesBySolutionDetails REVENUES BY SOLUTION (Details) Details http://www.sharpsinc.com/role/RevenuesBySolutionTables 38 false false All Reports Book All Reports smed-20170930.xml smed-20170930.xsd smed-20170930_cal.xml smed-20170930_def.xml smed-20170930_lab.xml smed-20170930_pre.xml http://xbrl.sec.gov/dei/2014-01-31 http://fasb.org/us-gaap/2016-01-31 true true ZIP 56 0000898770-17-000010-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0000898770-17-000010-xbrl.zip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end